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ABSTRACT 
 
 
Maternal smoking is known to cause serious health risks to the unborn child. Recent 
studies implicate nicotine as the causative factor. Maternal nicotine exposure during 
pregnancy and lactation interferes with foetal and neonatal lung growth and development, 
rendering the lung more susceptible to damage and diseases. Therefore, the aim of this 
study was to investigate: 1) the effect of maternal exposure to nicotine (1mg/kg BW/day) 
during all phases of lung development: 2) and vitamin C supplementation (0.5mg/kg 
BW/day) to prevent the adverse effects of maternal nicotine exposure on lung 
development in the offspring. This is based on studies in our laboratories which 
suggested that nicotine reduces the blood and tissue vitamin C content of the mother, 
thereby rendering the neonate more susceptible to oxidation damage. The chief 
motivation of this study was to establish whether an anti-oxidant, such as vitamin C, can 
be administered to smoking pregnant and lactating mothers in order to combat the 
deleterious effects of nicotine on the lung development of their offspring. It was found 
that although maternal nicotine exposure had no significant effect on the growth 
parameters of the offspring, it did have an effect on the development of the lung, 
compromising the ability of the lung to act as an organ of gaseous exchange. There was a 
decrease in the surface area available for gas exchange. The change occurred after the 
lung reached maturation and resembled microscopic emphysema. Vitamin C 
supplementation was unable to fully protect the neonatal lung against the adverse effects 
of maternal nicotine exposure; it however partially protected the neonatal lung against 
structural deterioration. Supplementation with vitamin C definitely offers possibilities as 
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a prophylactic to combat the detrimental influence of maternal nicotine-exposure on 
foetal and postnatal lung development. 
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CHAPTER 1 
 
Review of Literature 
 
 
1.1. Introduction 
 
Reports linking tobacco smoking with impaired health are numerous. Studies showed that 
cigarette smokers have the greatest risk of developing cancer of the oral cavity and throat. 
A number of respiratory diseases including emphysema and chronic bronchitis have been 
linked to the smoking habit (Huber, 1989). An alarming number of pregnant women in 
South Africa smoke despite being aware of the harmful consequences of smoking 
(Guthrie et al, 2001). In Cape Town, South Africa, a study conducted to show the 
prevalence of tobacco smoking among pregnant women indicated that ‘Coloured’ and 
‘White’ women had the highest rates amounting to 32.4 and 31.2% respectively, while 
‘Blacks (4%) ’ and ‘Indians (3%) ’had lower rates (Guthrie et al, 2001). It is important 
that pregnant and lactating mothers who smoke understand that they are putting their 
unborn and young children at risk to a wide range of respiratory and other health 
problems. It is plausible that the action of cigarette smoke on the surfactant-system 
contribute to the increase incidence of respiratory diseases (fig. 1.1), including premature 
death. 
Tobacco smoking during pregnancy is associated with adverse outcomes on the health of 
the foetus and infant. These include reduced birth weight and decreased gestational age 
(Davies and Albertiny, 1976). Colley et al (1973) link respiratory tract impairment in 
childhood to that in early adult life. Their study shows that childhood chest disease has a 
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more profound effect on the increased frequency of respiratory disability in early adult 
life than social class or air pollution.  
 
 
 
 
 
 
 
Fig.1.1. Examples of some potential sites where smoke exposure may alter surfactant metabolism. 
1: Particulates may have a direct detergent-like effect on the surface monolayer. 2: Lipid 
peroxidation induced by smoke exposure. 3: Transport of surfactant-specific phospholipids and 
altered secretion of lamellar bodies. 4 and 5: Reduced levels of SP-A and SP-D may affect 
hypophase processing directly or indirectly or alter SP-D regulation of DPPC synthesis. 6: 
Nicotine may alter receptor expression in foetal lung (Scott, 2004). 
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1.2. Nicotine 
 
Nicotine has been implicated as the causative agent in some tobacco-related lung 
diseases. It is associated with alterations in tissue remodelling and an increased matrix 
deposition. Nicotine is able to cross the biological membranes including the blood brain 
barrier. The rate of nicotine absorption through biological membranes thus increases as 
the pH of the aqueous solution increases, whereas nicotine absorption decreases as the pH 
decreases. At an alveolar pH of 7.4, nicotine is able to pass easily across the cell 
membrane onto the circulation (Yildiz, 2004). Absorption through the alveolar wall is 
also dependent on the nicotine concentration in the smoke. It has been shown that the 
plasma nicotine levels in non-inhaling smokers is around 2.5-8.0 ng/ml, whereas the 
plasma nicotine levels in inhaling smokers reach 30-40 ng/ml nicotine (Yildiz, 2004). 
These observations demonstrated that absorption of nicotine through the buccal mucosa 
is poor and absorption through the lung is rapid. 
 
About 70% of circulating nicotine is metabolized to cotinine, and it involves 
hydroxylation of nicotine by microsomal enzymes and conversion to the corresponding 
aldehyde. Pathways of nicotine metabolism can be divided into phase I and II metabolism 
of nicotine. The phase I metabolism involves the microsomal oxidation of nicotine and 
falls into four groups (figure 1.2, 1.3, 1.4) (Yildiz, 2004). 
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1. C – oxidation 
2. Formation of nornicotine 
3. N – oxidation 
4. N – methylation 
The phase II metabolism involves N – and – O glucuronidation of nicotine. 
                                                                                                                                                                                                 
Apart from many oxidants in cigarette smoke (Scott, 2004), nicotine has been known to 
result in oxidative stress by inducing the generation of reactive oxygen species (ROS) in 
tissues. These ROS in turn are capable of initiating and promoting oxidative damage in 
the form of lipid peroxidation (LPO) (fig. 1.1). Lipid peroxidation is known to cause 
cellular injury by inactivation of membrane enzymes and receptors, depolymerisation of 
polysaccharides, as well as protein cross-linking and fragmentation (MacNee, 2005). The 
mechanisms of ROS generation by nicotine are not clear. However, it has been reported 
that nicotine is chemotactic for polymorphonuclear (PMN) leucocytes and enhances the 
responsiveness of PMN leucocytes to activated complement C5a, thus generating ROS. 
Further, nicotine disrupts the mitochondrial respiratory chain leading to the increased 
generation of superoxide anions and hydrogen peroxide. Oxidative stress produces not 
only direct injurious effects in the lungs but also activates molecular mechanisms that 
initiate lung inflammation (MacNee, 2005). 
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               Fig.1.2. C-oxidation of nicotine (Yildiz, 2004). 
 
                Fig.1.3. C-oxidation and methylation of nicotine (Yildiz, 2004). 
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             Fig.1.4. N- and O-glucuronidation of nicotine (Yildiz, 2004). 
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For nicotine to directly affect lung development, nicotinic cholinergic receptors must be 
present in foetal lungs. Nicotine has been found to up-regulate the alpha-7-nAChR 
expression and chronic nicotine exposure permanently inhibits the function of many of 
these nAChR. The alpha-7-receptors are very sensitive to inactivation by nicotine. Thus, 
prenatal nicotine exposure most likely leads to increased levels of inactivated α7-
receptors in the developing lung (Sekhon et al, 1999). This would alter normal 
cholinergic transmission both by blocking the normal functioning of receptors and by 
allowing unopposed signalling by other nicotinic receptor subtypes that are more resistant 
to inactivation by chronic nicotine. It is possible that nicotine directly stimulate alpha-7-
nAChR- bearing fibroblasts to lay down an excessive amount of connective tissue 
(Sekhon  et al, 1999). 
 
 
1.3. Lung Development  
 
1.3.1. Prenatal Lung Development 
Prenatal growth can be divided into a number of phases, which are ordered sequences of 
events, taking part at specific times and involving specific events. The phases of prenatal 
growth are the embryonic, pseudoglandular, canalicular, and terminal saccular stages 
(Farrell, 1982).  
 
1.3.1.1. Embryonic Phase  
Human lung develops from the laryngo-tracheal groove and start to separate the lung bud 
from the prospective oesophagus (Farrel, 1982). The left and right branches, which give 
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rise to the left and right lungs, are also developed of day 13 of gestation in rats 
(Rothschild et al, 1996).  
 
1.3.1.2. Pseudoglandular Phase  
This phase, when the pre acinar branching pattern of airways and blood vessels is 
established, occurs at week 17 of gestation. The development of connective tissue cells 
from mesenchymal stem cells in foetal rat lung have been described from as early as day 
15 of gestation (Collet and Des Biens, 1975).  
 
1.3.1.3. Canalicular Phase  
This phase takes place at approximately days 19 to 20 of gestation in rats (Farrel, 1982). 
There is an increase in the blood supply and a decrease in connective tissue, as well as a 
flattening of the respiratory epithelium that line the airways. The production of surfactant 
follows the differentiation of type-1 and type-2 alveolar cells.  
 
1.3.1.4. Saccular Phase 
Saccular phase in rats begins on day 21 of gestation (Thurlbeck, 1978). During this 
period of lung development, differentiation of the alveolar epithelium and the production 
of surfactant continue. The potential airspaces are filled with foetal pulmonary fluid, 
which is expelled at the onset of labour and during vaginal delivery. 
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1.3.2. Postnatal Lung Development 
Postnatal development of the rat lung occurs in three phases, referred to as the phases of 
lung expansion, tissue proliferation and equilibrated growth, respectively (Burri et al, 
1974). 
 
1.3.2.1 Rapid Lung Expansion  
During the phase of lung expansion, airspace volume in rats increases by approximately 
87 %. Lung volume increases proportionally to body weight during the first ten days of 
life and thereafter is related to lung volume (Burri et al, 1974).  
 
1.3.2.2. Phase of Rapid Alveolarisation  
During days 4-13 of postnatal growth, the phase of tissue proliferation, also known as the 
phase of rapid alveolarisation, occurs in rats (Burri et al, 1974). Secondary crests divide 
the primary saccule, leading to the formation of more definitive alveoli. There is 
formation of the secondary septa from the primary septa and divide the saccules and 
transitory ducts into alveolar sacs and alveolar ducts, respectively. This process is 
accompanied by the proliferation of myofibroblasts and lipofibroblasts, the former of 
which synthesizes collagen and elastin (Brody, 1983).  
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1.3.2.3. Equilibration Phase  
The phase of equilibrated growth from approximately postnatal days 14 to 20 in rats, the 
capillary endothelium is a single layer thick but capillary surface area continues to 
increase. The mean blood-air barrier thickness decreases, due to the continued formation 
of new alveoli and declining proliferation of tissue. There is decreased lung volume 
expansion, since the lung grows slower than the increase in body weight (Kauffman et al, 
1974). 
 
Each of these phases contribute to the development of the lung into a structural and 
metabolically mature and fully function organ that will meet the oxygen demands of the 
body. It is therefore, conceivable that interference with the “program” that control lung 
growth and development, may also have an adverse impact on lung growth and 
development and thus on lung structural, integrity and function as well as respiratory 
health. Various studies have indeed shown that maternal smoking result in a higher 
incidence of respiratory diseases in the offspring as well as negatively impacting on lung 
function (Davies and Albertiny, 1976; Bardy et al, 1993). Nicotine, an important 
component of tobacco smoke (Benowitz and Jacob, 1984) is considered to be the 
causative factor in some of the adverse effects of nicotine attributed to nicotine (Heusch 
and Maneckjee, 1998).  
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1.4. Nicotine and Lung Development 
Many studies have also implicated nicotine in human lung cancer. Nicotine is able to 
activate the kinase ERK2, which results in increased expression of the Bcl-2 oncoprotein 
and suppression of apoptosis (Roman, 2004). Glucose is an essential source of energy in 
lung tissue and is necessary for the functional development of the lung (Bourbon and 
Jost, 1982). Maternal nicotine exposure during gestation and lactation results in sustained 
suppression of glycogenolysis and glycolysis in lung tissue of the rat fetus and neonate 
(Maritz, 1987).  The lower glycogenolytic activity is due to a lower phosphorylase 
activity in the lungs of the nicotine exposed offspring (Maritz, 1986). The decrease in the 
glycolytic activity, and thus the flux of glucose through this pathway can be attributed to 
an inhibition of phosphofructokinase (Kordom et al, 2002). Both the persistent reduced 
glycolytic activity and high levels of cAMP are associated with premature onset of cell 
senescence (Kondoh et al, 2007). It is, therefore, plausible that the exposure of the 
offspring to nicotine during gestation and lactation and thus during all the phases of lung 
development, may induce premature senescence of lung cells of the offspring (Maritz, 
2008).  
Among the matrix molecules found to be highly expressed in tobacco-related lung 
disease is fibronectin. Cultured fibroblasts revealed that nicotine induces fibronectin gene 
transcription by acting on alpha-7-nAChRs, by eliciting an increase in intracellular 
cAMP, and by inducing the phosphorylation and nuclear translocation of CREB, a key 
transcription factor capable of initiating fibronectin gene expression (Roman et al, 2004). 
It’s also possible that, nicotine can induce the exaggerated deposition of fibronectin in the 
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lungs of animals exposed to tobacco. Newly deposited fibronectin, containing matrices 
are not inert, instead they affect cellular processes capable of modulating lung 
inflammatory and tissue repair responses. Fibronectin modulate many cellular functions 
such as cell adhesion, proliferation and apoptosis (Roman et al, 2004).  
 
The effect of nicotine on neonatal lung structure is reflected in a reduced radial alveolar 
count. This reduction in the radial alveolar count of lungs of nicotine-exposed rat pups is 
an indication of failure of alveolar development within the lung acini. It is indeed 
illustrated that maternal nicotine exposure during pregnancy and lactation interferes with 
elastogenesis in neonatal rat lung (Maritz and van Wyk, 1997). Since elastogenesis is 
essential for alveolar formation (Loosli and Potter, 1959), it is conceivable that nicotine 
will have an adverse effect on the connective tissue framework of the lung and thus lung 
function. Furthermore, maternal nicotine exposure also causes damage to the supporting 
connective tissue skeleton of neonatal rat lung (Dolley, 1995). 
 
The mechanical properties of the lung are largely determined by the connective tissue 
networks laid down during development. The macromolecules most important for lung 
mechanics and structural integrity are collagen, elastin, and proteoglycans. Elastin is also 
an important architectural component that influences lung development, predominantly 
during the alveolar stage. The effects of oxidants on elastic fiber homeostasis are most 
likely manifested through their ability to modulate the activity of proteinases, proteinase 
inhibitors, cross-linking enzymes, as opposed to a direct effect on elastin. Interference 
with the balance between protein synthesis and breakdown will cause damage to the 
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connective tissue framework and overtime result in emphysema (Maritz and van Wyk, 
2007).   
 
Recent identification of nicotinic acetylcholine receptors (nAChR) in pulmonary 
fibroblasts suggests that in utero nicotine exposure may alter collagen expression. 
Because the alpha-7-nAChR receptor is primarily a ligand-gated calcium channel, 
activation of the alpha-7-receptor leads to increased intracellular calcium and the 
inhibition of the alpha-7-receptor leads to decreased intracellular calcium. Linking 
intracellular calcium to collagen gene expression, it has been shown that increased 
intracellular calcium decreases collagen gene biosynthesis in human fibroblasts (Sekhon 
et al, 1999). This supports the hypothesis that prenatal nicotine exposure leads to 
inactivated alpha-7-receptors, decreased fibroblast intracellular calcium, and therefore 
increased collagen. It is important to point out that there are also likely to be effects on 
collagen degradation. Therefore, it is likely that the increased collagen levels in the 
nicotine-exposed fetal lungs results from both increased collagen synthesis and from 
decreased degradation (Sekhon et al, 1999). 
 
About 90% of collagen found in the lung is collagen type I and II. It is suggested that 
whereas collagen I predominantly plays a key role in providing tensile strength, collagen 
II mainly provides compliance. So if prenatal nicotine induces alterations in collagen type 
I and III, the will be changes in lung function (Lang et al, 1994).  
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Normal lung development and injury/repair utilize common mesenchymol–epithelial 
signalling pathways to maintain homeostasis. Epithelially–derived parathyroid hormone 
related protein (PTHrP) induces the differentiation of mesodermal alveolar interstitial 
fibroblast to lipid, containing interstitial lipofibroblast (LIF) via a PTHrP receptor– 
mediated, cAMP–dependent PKA pathway. The lipid–containing LIFs produce factors 
that induce the growth and differentiation of the adjoining type II cells, culminating in 
alveolar homeostasis. Factors that disrupt this cellular homeostatic mechanism by causing 
the transdifferentiation of lipofibroblast (LIFs) to myofibroblast (MYFs) lead to abnormal 
lung development and function. Nicotine induces pulmonary alveolar lipofibroblast- to- 
myofibroblast transdifferentiation. Alveolar interstitial lipo–to–myofibroblast 
transdifferentiation results in fail of alveolarization in the developing lung, which leads to 
an arrest in pulmonary growth and development. In the developing lung, myofibroblast 
are fewer in number and are predominantly located at the periphery of the alveolar septa 
where they very likely participate in the formation of new septa. However, in chronic 
lung diseases, myofibroblast not only increase in number but also are located in the 
center of alveolar septum in great abundance (Kehan et al, 2005).     
 
 
1.5. Vitamin C (Ascorbic Acid) 
Vitamin C is a six-carbon lactone that is synthesized from glucose in the liver of most 
mammalian species (fig.1.5). Humans do not synthesize vitamin C because they do not 
have the enzyme gulonolactone oxidase, which is essential for synthesis of the ascorbic 
acid. Vitamin C is an electron donor and therefore a reducing agent, it donates two 
electrons from a double bond between the second and third carbons of the 6-carbon 
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molecule. The reason why vitamin C is called an antioxidant is because by donating its 
electrons, it prevents other compounds from being oxidized. However, by the very nature 
of this reaction, vitamin C itself is oxidized in the process (Padayatty et al, 2003). The 
species formed after the loss of one electron is a free radical semidehydroascorbic acid or 
ascorbyl radical. Ascorbyl radical is relatively stable with a half-life of 10-5 seconds and 
is fairly unreactive (Padayatty et al, 2003). So it is possible that harmful free radicals can 
interact with ascorbate and the reactive free radical is reduced and the ascorbyl radical is 
formed in its place. Upon the loss of a second electron in ascorbyl radical, the compound 
formed is dehydroascorbic acid. Once formed, ascorbyl radical and dehydroascorbic acid 
can be reduced back to ascorbic acid by at least three enzyme pathways, as well as by 
reducing compound in biological systems such as glutathione. In humans, there is only 
partial reduction back to ascorbic acid, therefore all the ascorbic acid that is oxidized is 
not recovered (fig. 1.6). If dehydroascorbic acid is not reduced back to ascorbic acid, it is 
hydrolyzed irreversibly to 2, 3-diketogulonic acid. This compound is formed by 
irreversible rupture of the lactone ring structure that is a part of ascorbic acid, ascorbyl 
radical and dehydroascorbic acid. 2, 3–diketogulonic acid is further metabolized into 
xylose, xylonite and oxalate. The formation of oxalate has clinical significance because 
hyperoxaluria (over excretion of oxalate) can result in oxalate kidney stones in some 
people (Padayatty et al, 2003). 
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Fig.1.5. Vitamin C synthesis pathway and pentose pathway in animals. The reactions are 
catalyzed by the following enzymes: 1, UDP-glucose pyrophosphorylase; 2, UDP-glucose 
dehydrogenase; 3, nucleotide pyrophosphatase; 4, UDP-glucuronosyltransferase; 5, UDP-
glucuronidase; 6, phosphatase; 7, β-glucuronidase; 8, glucuronate reductase; 9, gulonolactonase; 
10, L-gulonolactone oxidase; 11, L-gulonate 3-dehydrogenase; 12, decarboxylase; 13, L-xylulose 
reductase; 14, xylitol dehydrogenase; 15, D-xylulokinase. Three possible mechanisms for 
glucuronate formation (a, b and c) are shown (Linster and Van Schaftingen, 2007). 
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                  Fig.1.6. Recycling of vitamin C (Linster and Van Schaftingen , 2007). 
 
Vitamin C is transported into the cell under its reduced (ascorbate) and oxidized (DHA) 
forms by active and facilitative transport systems, respectively. The utilization of 
ascorbate as an antioxidant or enzyme cofactor leads to the formation of SDA in the 
cytosol, neuroendocrine secretory vesicles and the extracellular medium. Various 
enzymatic systems reconvert SDA to ascorbate. Intracellular DHA, arising through 
disproportionation of SDA or import from external sources, can also be reduced back to 
ascorbate by several enzymes or through spontaneous reaction with GSH. DHA, 
dehydroascorbate; GSTO, Omega class glutathione S-transferase; 3-hydroxysteroid DH, 
3-hydroxysteroid dehydrogenase; PDI, protein disulfide isomerase; SDA, 
semidehydroascorbate. (Linster and Van Schaftingen , 2007). 
 
Vitamin C acts as an electron donor for eight different enzymes. Three participate in 
collagen hydroxylation; these reactions add hydroxyl groups to the amino acid praline or 
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lysine in the collagen molecule. Two other vitamin C dependent enzymes are necessary 
for synthesis of carnitine, where carnitine is essential for the transport of fatty acids into 
mitochondria for ATP generation. Other three vitamin C dependent enzymes have the 
following function, one participate in the biosynthesis of nor epinephrine from dopamine, 
one adds amides groups to peptide hormones, greatly increasing their stability, one 
modulates tyrosine metabolism (figure 1.6) (Linster  and Van Schaftingen , 2007). 
 
The extracellular lining of the alveolus, which comes in close contact with cigarette 
smoke, is enriched with ascorbic acid. It is estimated that the ascorbate concentration of 
alveolar lining fluid of rat is 6.3 mmol/L. This considerably higher than the 0.1 mmol/L 
ascorbate concentration in normal rat serum. Ascorbic acid is more abundant in the fluid   
lining the alveolar than its oxidized metabolites, dehydroascorbate (McGowan et al, 
1984). This implies that ascorbic acid acts as a first line of defence against inhaled 
oxidants. It furthermore means that a lowering in the ascorbic acid content in this fluid 
lining, such as during inhalation of cigarette smoke, will reduce the capacity of the lungs 
to protect itself (Bui et al, 1992). 
 
 
1.5.1. Ascorbic Acid and Collagen formation 
Proline monooxygenase is an enzyme that plays a role in the maturation of collagen. It 
catalyzes the conversion of specific proline residues to hydroxyproline. The enzyme does 
not hydroxylate free proline, though it can act on small peptides containing proline 
(McGowan et al, 1984). Molecular oxygen is the source of the oxygen atom in the 
hydroxyl group of hydroxyproline. In common with many other oxygen-using enzymes, 
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proline monooxygenase contains an iron atom. Hence, the enzyme is an iron 
metalloenzyme.  The iron must be in the reduced (ferrous iron, Fe2+), rather than in the 
oxidized state (ferric iron, Fe3+) to support catalytic activity. A general property of 
ferrous iron is that it is not particularly stable. It can spontaneously oxidize to the ferric 
state. Ascorbate plays a vital role in maintaining the enzyme’s iron in the reduced state. 
The conversion of ferrous to ferric iron in the enzyme is not coupled to each event of 
hydroxylation, in other words, the conversion is not an obligatory component of the 
hydroxylation reaction. The oxidation of iron appears to occur after every ten to twenty 
hydroxylation events. Then the iron must be re-reduced for enzyme catalysis to continue. 
Ascorbic acid reduces the iron again and, in turn, is converted to semidehydroascorbate 
(Brody, 1994).  
 
Vitamin C deficiency results in impairment in the hydroxylation of collagen. Properly 
hydroxylated collagen molecules self-associate to form a triple-helix structure within the 
cell. Collagen that is not hydroxylated and does not form the triple helix is not readily 
secreted from the cell and its secretion is impaired (McGowan et al, 1984).    
 
1.5.2. Vitamin C as an Antioxidant in human biology 
The species which receive electrons and are reduced by vitamin C can be divided into 
several classes: 
1. Compounds with unpaired electrons (radicals) such as oxygen
 
related radicals 
(superoxide, hydroxyl radical and peroxyl radicals). 
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2. Compounds that are reactive but are not radicals, including hypochlorous acid, 
nitrous acid related compounds. 
3. Compounds that are formed by reactions with either of the first two classes and 
then react with vitamin C, e.g. alpha tocopheroxyl radicals. 
4. Transition metal-mediated reactions involving iron and copper for example 
reduction especially of iron by ascorbate can lead to formation of other radicals 
(Padayatty et al, 2003). 
Oxidants can react with three general classes of biomolecules. 
1. Lipids. 
2. Proteins. 
3. DNA. 
Lipids, membrane lipids and lipids in circulating lipoproteins such as low density 
lipoproteins (LDL) can interact with reactive oxygen species resulting in lipid 
peroxidation. Once lipid peroxidation form, they can react with oxygen to form highly 
reactive peroxyl radicals, and continued formation of lipid hydroperoxidation can result, 
a process termed radical propagation. Ascorbate can reduce the initiating reactive oxygen 
species so that initial or continued lipid peroxidation is inhibited (Brody, 1994). 
 
Proteins also undergo oxidation by several mechanisms, a peptide chain can be cleaved 
by oxidants, or specific amino acids can be oxidized. The two amino acids most prone to 
oxidative attack are probably cysteine and methionine. Oxidation processes can affect 
DNA indirectly through protein oxidation and lipid oxidation or directly by oxidation of 
DNA. Guanine is the DNA base most susceptibly to oxidative attack. DNA can also be 
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damaged by reactive nitrogen species, derived from nitrosamines e.g. nitric oxide 
radicals. Once nitrosamines give rise to reactive nitrogen species, prevention of 
mutagenic activity by ascorbate is less effective in prevention of DNA damage 
(Padayatty et al, 2003). Damage to DNA may result in changes in the “program” that 
control lung growth, development and aging, and induce fetal onset of adult respiratory 
diseases (Maritz, 2008). 
 
1.5.3. Vitamin C concentration in humans as a functional dose 
At plasma vitamin C concentration less than 4 µM, symptoms of scurvy may occur. Oral   
doses of 30 mg daily yield a steady-state plasma concentration of approximately 7 µM for 
men and 12 µM for women (Padayatty et al, 2003). Tight control of vitamin C 
concentration is mediated by tissue transport, absorption and excretion. The higher the 
dose, the less absorption occurs. Vitamin C reabsorption and excretion by the kidney play 
a key part in tight control of plasma and tissue vitamin C concentrations in healthy 
humans, and this control is lost in patients with end stage renal disease. In the kidney, 
vitamin C is filtered through the glomerulus’s and reabsorbed in the proximal tubule by 
vitamin C transporters SVCT1. When the transporters absorption mechanism approaches 
maximal velocity, additional vitamin C cannot be absorbed and is lost in urine. Its also 
important to note that ascorbate entry into mammalian cells is energy-dependent, being 
effected by two distinct Na+ dependent co-transporters, SVCT1 and SVCT2, which show 
distinct distributions. But dehydroascorbate (DHA) is transported by glucose transporters, 
particularly GLUT1, GLUT3 and GLUT4, and is therefore not energetically driven 
(Linster and Van Schaftingen, 2007).  
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Glutathione and vitamin C are thought to be the most abundant reducing agents in cells. 
Furthermore, glutathione is implicated in vitamin C recycling from DHA. It would make 
therefore sense for glutathione to exert a control on vitamin C synthesis. Several 
experiments performed with glutathione-depletion agents indicate that glutathione 
depletion favours vitamin C synthesis. Administration to adult mice of buthionine 
sulfoximine, an inhibitor of glutathione synthesis, led to a two-fold increase in the 
amount of vitamin C in the liver within 4 hours. 
 
Vitamin C, in addition to its function as an antioxidant, acts as a prooxidant and generates 
ascorbate free radical and reactive oxygen species in biological system in the presence of 
transition metal ions (Fe2+). The endothelium, a semipermeable barrier that plays a 
pivotal role in the maintenance of vascular integrity and function, is a prime target for the 
high levels of circulating prooxidants vitamin C (Kalpana et al, 2007), presumably 
leading to altered integrity of the endothelium (fig. 1.7) . It has been reported that vitamin 
C, upon infusion into blood at a dose of 10mg/min for 120 minutes, improved the 
impairment of endothelial function in smokers.  
 
Endothelial dysfunction is well established as one of the primary events in the 
pathogenesis of etherosclerosis. Monocyte-endothelial interactions have been implicated 
in the initiation of endothelial dysfunction seen in many chronic cigarette smoking. 
(Fennessy, 2003) 
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Fig.1.7. Scheme of the proposed mechanism of vitamin C-induced PLD activation through 
MAPK regulation in the lung microvascular ECs. (Varadharaj et al, 2005). 
 
Endothelin-1 (ET-1), an endothelial–derived peptide, is a potent vasoconstrictor and 
growth promoter that has a short plasma half-life, but a prolonged onset and duration of 
action. Impaired-flow-mediated dilatation (FMD) has been demonstrated by ultrasonic 
insonation in the brachial arteries of young otherwise healthy cigarette smokers. In FMD 
of the brachial artery, endothelial NO synthase (eNOS) is activated by the forces of 
increased sheer stress and stretch with the resultant release of NO, which induces 
relaxation of smooth muscle cells in the vessel wall. Vitamin C improves, but does not 
restore the normal dilatory response of the brachial artery to increase flow (Fennessy et 
al, 2003). 
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At pharmacological doses, vitamin C exposed to bovine lung microvascular endothelial 
cells (BLMVECs) shows formation of intracellular ascorbate free radicals ROS is dose 
and time dependent, leading in to alterations and loss of redox-dependent cell viability 
(Varadharaj et al, 2005). Exposure of BLMVECs to vitamin C increased the formation of 
extracellular and intracellular H2O2 in a dose dependent manner. Vitamin C, at 
pharmacological doses, induced activation of PLD in BLMVECs through oxidative stress 
and upstream activation of p38 MAPK and ERK1/ERK2. At a concentration of 5.7 and 
10 mM for 120 minutes, the BLMVECs exhibited marked alterations in their cell 
morphology with considerable gaps between cells and formation of filopodia and 
lamellipodia. Vitamin C was able to cause a significant depletion of GSH (50% 
depletion) even at 1 mM concentration. At 3.5 and 10 mM concentration of vitamin C, 
futher depletion of intracellular GSH to 64%, 72% and 80% in BLMVECs at 120 
minutes, it is clear that vitamin C at pharmacological doses induces oxidative stress and 
loss of redox-dependent cell viability in BLMVECs (Varadharaj et al, 2005). 
 
 
1.6. Lung Maintenance 
Homeostatic alveolar maintenance requires a proper extracellular matrix maintenance, 
which means that inhibition of extracelleular matrix deposition may lead to experimental 
emphysema. Furthermore, abnormalities of elastin fiber deposition lead to developmental 
lung arrest and an overall simplification of alveolar structure with airspace enlargement 
(Tuder et al, 2006). It has been proposed that alveolar destruction in emphysema involves 
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feedback interactive loops among apoptosis, oxidative stress, and excessive lung 
extracellular matrix proteolysis (fig. 1.8), (Tudor et al, 2006). 
 
 
 
 
 
Fig.1.8. Conceptual framework of positive interaction among apoptosis, protease/antiprotease 
imbalance, and oxidative stress in emphysema (Tuder, 2006). 
 
In alpha-1-antitrypsin (A1AT)–deficient patients, emphysema occurs in a more global 
pattern, affecting all lobes, and involving microscopically most of the primary lobule that 
is, both the centrilobular and the peripheral components of the alveolar units connected to 
the respiratory bronchiole. The nature of the widespread alveolar destruction in alpha-1-
antitrypsin (A1AT)-deficient patients remains unclear. With the increasing understanding 
that emphysematous lung destruction involves excessive proteolysis, apoptosis, and 
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oxidative stress, the association of A1AT deficiency with panlobular destruction may be 
explained if all three elements of this pathologic triad synergistically and simultaneously 
operate in the lung destruction in A1AT-deficient patients (fig. 1.9) (Tuder, 2006). 
 
 
 
 
 
 
Fig.1.9. Pathogenesis of alphar-1-antitrypsin (A1AT) deficiency. A1AT deficiency (ZZ variant) 
may lead to a more global alveolar destruction since it causes (1) oxidative stress via its 
proinflammatory properties when polymerized, (2) loss of the antiprotease shield, and (3) loss of 
anti–active caspase-3 activity (Tuder, 2006). 
 
Carbohydrates play an important role in the structural and functional development and 
maturation of foetal and neonatal lung tissue. The whole process of lung development 
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(cell growth and formation of connective tissue framework) depends on ATP energy 
derived from carbohydrate metabolism (Maritz and Najaar, 1994). 
 
The environment imposes continuous biological selection, with consequences related to 
aging, as macromolecular damage accumulates and progressively overwhelms organ 
defences. There are molecular sensors that respond acutely to environmental stresses, 
such as those imposed by hypoxia or nutrient deprivation. RTP-801 or REDD1 (  
Regulated in development and DNA damage responses) a repressor of the mammalian 
target of rapamycin (mTOR), was initially discovered as a hypoxia-inducible factor 
(HIF)-1-alphar–inducible protein, whose expression is modulated by oxidative stress and 
capable of inducing apoptosis when over expressed in lungs of mice (Tuder et al, 2006). 
It has been recently observed that mice exposed to cigarette smoke show acute lung up-
regulation of RTP-801. Interestingly, TSC-2 down-regulates VEGF both dependently and 
independently of its inhibitory effects on mTOR. The inhibition of mTOR decreases S6-
kinase-phosphorylation, causing its inactivation, and stabilizes 4eBP1 (an inhibitor of the 
ribosomal machinery), both leading to decreased protein translation (fig. 1.10), (Shoshani 
et al, 2002). 
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Fig.1.10. RTP-801 and growth or inhibitory cell signaling in cells exposed to nutrients or 
environmental stresses, respectively. RTP-801 activates tubersclerosis complex hamartin and 
tuberin proteins (TSC1 and TSC2, respectively), which via inhibition of Rheb kinase lead to 
mTOR inhibition and suppression of protein translation. mTOR is usually activated under 
conditions favoring cell growth during abundance of nutrients or due to insulin signaling. The 
activation of RTP-801 is targeted for cell protection during stress; however, given the nature of 
the environmental stress, overexpression of RTP801 may cause apoptosis, oxidative stress, or 
excessive inflammation. AKT = protein kinase B; P-AKT = phosphorylated AKT; PI3K = 
phosphotidylinositol 3-kinase; RHEB-GTP = RHEB-GTPase (Shoshani et al, 2002). 
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Fibroblast play an important role in the maintenance of alveolar structure as a change in 
fibroblast phenotype could be involved in the pathogenesis of emphysema. Lung 
fibroblasts from patients with emphysema show a reduced proliferation rate and altered 
growth factor response. Senescent cells (e.g. fibroblast) not only loose their ability to 
divide and respond to mitogenic stimuli but also display alterations in morphology and 
metabolic profile. As fibroblasts provide part of the lungs structural support and matrix 
that is essential for its integrity, so a senescent phenotype could affect tissue 
microbalance and structural maintenance of the lung (Muller, 2006).   
 
1.7. Cellular and Lung Senescence 
It is found that cigarette smoke is able to stop the proliferation of lung fibroblast and up-
regulate two pathways linked to cell senescence, namely a biological process associated 
with cell longevity and an inability to replicate (Tsuji et al, 2006). Cellular senescence is 
defined as complete and irreversible loss of replicative capacity accruing in primary 
somatic cells (fig. 1.11). Major characteristics of a senescent cell are the following: 
1. A distinct flat and enlarged cell morphology. 
2. Resistance to apoptosis. 
3. Altered production of inflammatory and growth mediators. 
4. An increase in senescence associated β-galactosidase activity  
      (Nyunoya et al, 2006). 
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One major anatomical change found in the aging lung is smaller airways size, principally 
due to alterations in the supporting connective tissue. Other anatomical changes 
associated with aging include an increase in the diameter of alveolar sacs. These 
morphologic changes are considered to be due to changes in the relative proportion of 
decreased elastic tissue and increased collagen that occur with aging (fig. 1.12) (Chan 
and Welsh, 1998). 
 
 
Fig.1.11. Simple schematic comparing (a) the cell senescence hypothesis of ageing (right hand 
flow) with (b) the dysdifferentiation hypothesis of ageing (left hand flow). The cell senescence 
hypothesis postulates that in the normal course of life there is cell loss. That loss is balanced by 
cell division which is actively monitored. One or more “replicometers” act to trigger permanent 
cell cycle exit (senescence) in individual cells. Cell cycle exit is associated with a broad alteration 
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in gene expression leading to an altered phenotype that affects the microenvironment in which the 
cell resides and ultimately the entire tissue. In the dysdifferentiation model chronic oxidative 
stress leads to a regearing of gene expression generating an altered cellular phenotype which 
contributes to tissue ageing. The two models have many essential similarities (Bird et al, 2003). 
 
 
 
Fig.1.12. Schematic representation of lung volume changes associated with aging. Note that with 
senescence, there is a decrease in the inspiratory reserve volume (IRV9), the expiratory reserve 
volume (ERV9), and the vital capacity (VC9). There is a corresponding increase in residual 
volume (RV9) and functional residual capacity (FRC9) such that the TLC remains about the same 
TV 5 tidal volume (Chan and Welsh, 1998). 
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Major physiological changes that occur in the aging respiratory system may reflect 
several mechanistic/structural changes including the following: 
1. Diminished lung elasticity. 
2. Increased stiffness of the chest wall. 
3. A reduction in respiratory muscle strength (Chan and Welsh, 1998). 
 
The aging alveolus actually becomes shallower, containing less air. On average, aged 
alveoli are surrounded by larger pores, which also contribute to the diminished surface 
area. The is a generalized reduction in the number and thickness of elastic fibers with 
advancing age, particularly in the alveolar ducts, consistent with a loss of elastin 
(Nyunoya et al, 2006). 
 
The disappearance of lung tissue during the development of emphysema may involve the 
progressive loss of capillary endothelial and alveolar epithelial cell through the process of 
programmed cell death (apoptosis). One known survival factor for endothelial cells is 
VEGF (vascular endothelial growth factor), initially characterized as a factor that 
increases endothelial permeability and induces endothelial cell growth. Withdrawal of 
VEGF leads to endothelial cell apoptosis in vitro and in vivo. It is postulated that VEGF 
signalling may be required for the maintenance of adult lung alveolar structures 
(Kasahara and Tuder et al, 2000). 
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CHAPTER 2 
 
Statement of problem 
 
The aim of the current investigation was to study the effect of maternal nicotine exposure 
and supplementation with vitamin C on the development of the airways of the rat lung 
throughout the entire period of gestation and lactation.  
 
This will give an understanding of when nicotine is most harmful to the development of 
the lung of the offspring. It will also give a better understanding of the site of action of 
nicotine and help to develop a strategy to prevent the harmful effects of maternal nicotine 
exposure on the development of the respiratory system of the offspring.  
In particular, it is the aim of this project to describe:  
1. The phase(s) of lung development in which nicotine induces changes in lung 
structure and the possible consequences thereof to lung function.  
2. The long-term consequences of maternal nicotine exposure on lung 
development of the offspring.  
3. To discuss strategies which may prevent the adverse effects of maternal 
nicotine exposure on lung development of the offspring.  
 
In this study, the offspring were exposed to nicotine, vitamin C and a combination of 
nicotine and vitamin C via the placenta or mother’s milk. Since nicotine has oxidant 
properties it might interfere with lung development (Sekhon et al, 1999). It was 
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previously shown that maternal nicotine exposure reduces the vitamin C content of the 
lungs of the offspring (Maritz and van Wyk 1997)and thus the anti-oxidant capacity of 
the nicotine exposed lungs. Therefore, vitamin C was given to the pregnant mothers to 
improve the anti-oxidant capacity of the nicotine exposed lungs and therefore, its ability 
to protect itself against the oxidant effect of nicotine. In this study morphometric and 
morphologic methods will be used to study the impact of maternal exposure to nicotine 
only, or vitamin C only, or a combination of nicotine and vitamin C on lung 
development, and maintenance of lung integrity of the offspring in the long term. The 
morphometric methods involve quantification of parameters of lung growth and 
maintenance such as alveolar numbers (Na), internal surface area (ISA), lung volume 
(Lv), alveolar volume (Valv) and others. For histological evaluation lung tissue samples of 
the lungs of the offspring was stained with haematoxylin and eosin for assessing the 
status of the lung parenchyma and to visualize changes such as microscopic emphysema. 
Staining for connective tissue was done to visualize the connective tissue for assessment 
of integrity. This may help to explain the site of action of nicotine. 
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CHAPTER 3 
 
Materials and Methods 
 
 
3.1. Experimental animals 
The animals used in this study were virgin white rats from the Wistar strain and were 
bred in the animal laboratory of the Department of Medical Bioscience Science at the 
University of the Western Cape. Only animals free from visible signs of diseases and ill-
health were used in the study. Animals were fed a stock diet of Epol rat cubes, and they 
had fresh drinking water. The rats were kept in a controlled environment to eliminate 
factors such as noise and unnecessary handling. The ambient temperature was maintained 
at 25 ± 1oC and a 12-hour light cycle was maintained. 
 
The animals were mated for a week after which the sires were removed. The females 
were randomly divided into four experimental groups. The body weight of each female 
was recorded daily for the next seven days. A significant mass increase over this time 
indicated that mating was successful. The pregnant rats were placed in individual straw 
lined cages for the duration of the study. 
 
From gestational day seven to day 21 post partum, the rats were given treatment as 
designated by the experimental group. Nicotine treated animals received 1 mg/kg body 
mass/day subcutaneously, whereas vitamin C treated rats received 0.5 mg/kg body 
mass/day. The control animals received a placebo of water to the dose of 1 mg/kg body 
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mass/day. Finally, the last experiment group was subjected to the following procedure: an 
injection of 0.5 mg vitamin C/kg body mass/day followed by injection of 1 mg 
nicotine/kg body mass/day. The dose of 1 mg/kg body mass/day subcutaneously lies 
within the range of intake of 0.16 to 1.8 mg/kg body mass/day of habitual smokers 
(Maritz and Woolward, 1992). 
 
The animals were injected daily between 9h00 and 10h00 using 1.0 ml plastic disposable 
syringes and needles. Care was taken during handling and injection of the animals not to 
inflict pain and to prevent discomfort of the animals. 
 
 
3.2. Excision of lung tissue 
 
Lung tissue for each of the experimental groups was obtained from the pups at week two, 
three and six. In each of the age groups a total of between 5 and 13 lung samples were 
obtained. Body weight was determined by weighing pups on a top loader laboratory 
balance (Denver instrument). Animals were then sacrificed by intraperitoneal injection of 
an overdose of 0.5 ml pentobarbital. The trachea was ligated and lungs were infused with 
10 % formaldehyde. Lungs were fixed at a pressure of 25 mm Hg and 40 mm Hg in situ 
for 5 minutes, after which it was removed en bloc, and the lung were fixed in 10 % 
buffered formalin until processing. 
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3.3. Intratracheal instillation  
  
Intratracheal instillation is, for the most part, a simple reliable method, as it gives 
complete unfolding of the alveoli, preserves the vascular bed and shows minimal 
shrinkage. The trachea was surgically exposed and the diaphragm punctured in order to 
remove air from the lungs. The fixative was allowed to run into the lungs, whilst a 
transpulmonary pressure gradient of 25 cm fixative was maintained for approximately 30 
minutes. The canula was then quickly and carefully removed and the ligature secured to 
ensure that no fluid escaped. The entire lung was removed by careful dissection and the 
trachea was cut off dorsal to the ligature. Lung tissue was then placed in fixative for 24 
hours before histological processing.  
 
3.4. Measurement of Lung Volume  
 
The lung volume was measured by the fluid displacement method. A beaker containing 
physiological saline was placed on a scale and weighed. The lung was immersed into the 
beaker with the aid of a forceps at a level of buoyancy and the initial weight (beaker + 
saline) subtracted from the final weight (beaker + saline + tissue) to obtain the lung 
volume. The specific gravity of physiological buffered saline is 1.0048 and therefore no 
correction was made to adjust lung volume. The lung was then placed in sample vials 
filled with buffered formalin at a pH of 7.2.  
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3.5. Sampling design 
 
 
 
 
Fig.3.1. Illustration of a cascade sampling design in the lung, and the principles of systematic 
uniform random sampling have to be applied.  (A) At the macroscopic level, the lung is cut 
completely into horizontal slices of thickness t, starting at a random position between 0 and t 
(arrow). (B) These slices can be used for the estimation of total lung volume by the Cavalieri 
principle as well as for sampling of tissue blocks for light microscopy. Total lung volume [V 
(lung)] is the product of t and the total cut area of the apical side of all slices (shown in red). (D) 
At a low light microscopic magnification, the volume fraction of parenchyma within lung [Vv 
(par/lung)] is estimated by point counting.  
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3.6. Embedding and processing 
After proper fixation in 10% buffered formaldehyde, the left lobe of the lung of each 
sample was placed in a plastic tissue processing cassette. Tissue was processed in a tissue 
processor, using fresh reagents for each processing cycle. The processing procedure 
involved is outlined in table 3.6. 
 Reagents Time (hr) 
1 70% ethanol 1 hr 
2 80% ethanol 1 hr 
3 90% ethanol 1 hr 
4 absolute ethanol 1 hr 
5 absolute ethanol 1 hr 
6 xylene I 1 ½ hr 
7 xylene II 1 ½ hr 
8 wax bath I 2 hrs 
9 wax bath II 2 hrs 
Table 3.6.  Lung tissue processing procedure. 
An embedding system was used for this process, prior to completing the embedding 
process, care was taken to standardise the orientation of all the lobes: the lateral aspect of 
each lobe was positioned such that it faced downward in the mould, with the superior 
aspect pointing to one of the short sides of the oblong mould. A very small volume of 
wax was then run slowly into the mould, the mould was placed on the refrigerated plate 
of the embedding system just long enough to permit the wax to start solidifying – thus 
securing the tissue in the required orientation. The mould was then removed from the 
refrigerated plate and the cassette was positioned such that the superior aspect of the lobe 
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was nearest to the pointed end of the cassette (fig. 3.2). The mould plus cassette was then 
filled with sufficient wax to permit proper adhesion to the cassette after the waxed 
solidified. 
 
 
 
 
Fig.3.2. Line diagram illustrating the standardised orientation of the processed lobe during the 
embedding process. 
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3.7. Microtomy  
The tissue blocks were trimmed and sections of 5 µm were cut for haematoxylin and 
eosin (H&E) staining and transferred onto microscope slides, by allowing the wax ribbon 
to float in a warm water bath. Sections of 5 µm were cut to stain for elastic tissue. Tissue 
and tissue blocks that were inadequately processed or embedded were excluded from the 
study. Sections that broke up easily when placed in the water bath were also excluded 
from the study.  
 
3.8. Microscope slide preparation 
Sections of 5 µm were made by means of a precision rotary microtome (model: RMT-
30). In order to ensure that the sampling was indeed from different levels in the lobe, and 
to eliminate the possibility that a section of the same alveolus appear in samples from two 
consecutive levels. So the 5 µm sections were obtained from the embedded tissue as 
follows: 
1. Nearest to the lateral aspect of the lobe – level designated A. 
2. In the paramedian plane of the lobe – level designated B.  
3. Nearest to the medial aspect of the lobe – level designated C. (fig. 3.3) 
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Fig.3.3. Line diagram of embedding lobe in profile, illustrating the protocol followed to obtain 
tissue sections from the three designated levels, namely A, B and C. Sectioning was executed 
from the superior to the inferior end of the lobe. 
 
After cutting, the sections were floated on a water bath from where it was picked up on 
clean, marked microscope slides. Sections were fixed onto the glass slide in an incubator 
at 37oC for an hour, after which they were then stored in microscope slide boxes until 
staining could be executed. 
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3.9. Mayer’s haematoxylin and eosin staining technique 
Haematin, the oxidation product of haematoxylin, is the natural dye that will cause 
staining of the tissue; the oxidation process is aided by sodium iodate. The poor affinity 
of haematoxylin for tissue is remedied by adding a mordant (aluminium salt) to the 
preparation. The nuclei of the tissue are stained a red colour, which is blued in the Scott’s 
Tap water to a dark blue shade. The cytoplasm is stained a reddish pink with eosin, the 
counterstain. 
3.9.1. Reagents: 
1. Xylene: Use as supplied by the manufacture. 
2. Ethanol: Use in the following concentrations: absolute (as supplied by the 
manufacturer); 90%; 80% and 70%. The dilutions are done using distilled 
water. 
3. Eosin: Dissolve 3.0 grams of eosin and 2.0 grams of phloxine in 1 litre 
distilled water. 
4. Mayer’s alum haematoxylin: Combine 1.0 gram haematoxylin and 50.0 grams 
of potassium alum and dissolve in a small volume of water. Add 0.2 grams 
sodium Iodate, make up to a volume of 1 litre and leave to dissolve overnight 
at room temperature. Then add 50.0 grams chloral hydrate and 1.0 grams of 
citric acid and boil fro 5 minutes. When cool. It is ready for use. 
5. Scott’s Tap water: Dissolve 2.0 grams sodium bicarbonate and 20.0 grams 
magnesium sulphate in 1 litre distilled water. 
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6. 1% acid alcohol: Combine 1.5 litres of 96% ethanol with 0.48 litres of 
distilled water and 0.02 litres of concentrated hydrochloric acid. Mix well to 
form a homogeneous solution. 
7. DPX: Use as supplied by the manufacturer. 
3.9.2. Procedure: 
1. Sections were fixed onto glass slides for 30 minutes in a hot air oven at 80oC. 
2. Glass slides with sections were transferred to xylene and gently agitated for 1 
minute and repeated on second xylene bath to remove any remaining traces of 
wax. 
3. Transferred to absolute alcohol to initiate the hydration process 
4. Continued the hydration process by repeating the procedure described in (3) in 
90%, 80% and 70% ethanol. 
5. Completed the hydration process and washed well in running tap water. 
6. Stained in Haematoxylin for 15 minutes. Gently agitating the slides. 
7. Washed in running tap water. 
8. Sections were differentiated in 1% acid alcohol, and rinsed under tap water. 
9. Sections were blued in Scott’s tap water for 30 seconds, and then rinsed under tap 
water. 
10. Stained in Eosin for 1 minute. Washed in running tap water to rinse excess 
staining. 
11. Sections were dehydrated for 30 seconds each in 70%; 80%; 90% and absolute 
alcohol. 
12. Slides were cleared in two successive xylene baths, 30 seconds each. 
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13. Slides were mounted with DPX. 
 
3.10. Verhoeff’s Method for Staining of Elastic Fibres  
 
3.10.1. Materials 
 
3.10.1.1. Staining Solution  
10% Alcoholic haematoxylin      2.5ml  
Absolute alcohol                          2.5ml  
10% Ferric chloride                     2ml  
Lugol’s iodine                              2ml  
3.10.1.2. Lugol’s Iodine:  
        Iodine                                           1g  
                 Potassium iodide                          2g  
                 Distilled water                             100ml  
3.10.1.3. Van Gieson:   
                Saturated aqueous picric acid      100ml  
                1% acid fuschin                            10ml 
 
3.10.2. Procedure 
 
 1. The sections were washed with distilled water.  
 2. The stain was poured on the slides for approximately 20 minutes.  
 3. The slides were washed in water and the bottom of the side was cleaned.  
 4. The slides were differentiated in 2% ferric chloride and checked 
microscopically.  
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 5. The slides were rinsed in 96% alcohol for 5 minutes.  
 6. The slides were rinsed in distilled water.  
 7. The slides were counterstained with Van Gieson for three minutes.  
 8. They were then rinsed in distilled water.  
 9. The slides were dehydrated in alcohol, cleared in xylene and mounted with 
DPX mountant.  
 
3.11.   Van Gieson’s Method for Staining of Collagen Fibres 
 
            
              3.11.1. Preparation of solution: 
 
1. Any of alum haematoxylins may be used; or better, iron 
haematoxylin. 
2. Van Gieson’s picro-acid-fuchsin: 1% aqueous acid fuchsin, 5-15 
ml, saturated aqueous picric acid (about 1.22%), 100ml. 
 
3.11.2. Staining schedule: 
1. Dewaxed, hydrated and applied nuclear stain. 
2. Washed the slides with distilled water. 
3. Stained for 3-5 minutes in Van Gieson’s solution (Solution B) 
4. Washed quickly in distilled water. 
5. Dehydrated the slides through ascending alcohols.  
6. Cleared and mounted. 
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3.12. Morphometric Techniques 
Various morphometric techniques can be used to assess abnormal lung development. Six 
of these techniques namely: lung volume (VL), mean linear intercept (Lm), internal 
surface area (ISA), volume density of tissue (Vt) and air (Va), lung alveolar volume (Valv) 
and alveolar number (Na) were used in this study to elucidate the effect that nicotine, 
ascorbic acid and nicotine plus ascorbic acid have on postnatal lung development in 
comparison with that of control animals. Used individually, the techniques quantify the 
effects that nicotine, ascorbic acid and nicotine plus ascorbic acid have on the lung. Used 
as a combination, it gives a global view of lung development and the extent of pulmonary 
damage due to nicotine exposure, as well as the possible preventative role of ascorbic 
acid where ascorbic acid plus nicotine was administered. The effect if ascorbic acid 
supplementation will also be assessed. Haematoxylin and eosin stained slides free of 
cutting artefacts were used for these assessment. Two microscope slides of each animal 
sample were used. At least six fields per microscope slide were counted. 
3.12.1. Protocol followed to investigate the effect of treatment and age on lung  
            development and damage:                                             
From the sample population, two microscope slide preparation per age group per 
treatment were randomly selected for inclusion in this sample population. Each 
microscope slide preparation represented the lung tissue of a different animal from a 
different litter. In addition, a suitable microscope slide preparation of the lung tissue of an 
additional five animals per age group per treatment was used. The total sample 
population used was therefore seven animals per age group, per treatment (n = 7). With 
respect to the radial alveolar counts, mean linear intercept and internal surface area, an 
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average of six fields were assessed per microscope slide preparation. Hence the total 
number of fields assessed per age group, per treatment was 42 (n = 42). 
3.12.2. Total number of alveoli per lung (Na)  
Tissue samples were taken randomly from the upper, middle and lower lung lobes. At 
least six tissue samples were taken per lung for processing for morphology and 
morphometry. Total number of alveolar was calculated as follows:  
 
Na = Lv.Va/ Valv 
Where:  
Lv = lung volume (ml)  
Va = alveolar air volume density (%)  
Valv = mean alveolar volume (ml) 
 
3.12.3. Volume Density (Va and Vt)  
The alveolar air volume density (Va) and alveolar tissue volume density (Vt) was 
determined by using the point counting technique at 100 x magnifications. A 121-point 
eyepiece graticule was used. For the purposes of this study, an alveolus was defined as an 
airspace either completely enclosed by respiratory epithelium, or having a smooth 
rounded contour for more than one third of a projected circle with the remaining 
boundary formed by an imaginary line between the distal ends of secondary septa.  
A 10 x eyepiece and a 10 x objective were used to obtain a total magnification of 100 x. 
Two blocks were taken from the upper lobe, one from the middle lobe and two from the 
lower lobe. Non-parenchyma included tissue which had a diameter of more than 1.1mm.  
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The following alveoli were included:  
 1. Those that were found within the graticule.  
 2. Those that touched the lower and right borders of the graticule.  
The alveoli that were excluded from the count included:  
 1. Those found outside the square on the upper and the left side of the graticule.  
 2. In addition, fields containing non-parenchymatous tissue were excluded from 
the counts. At least 25 randomly selected non-overlapping fields were 
analysed and 75 fields per animal were counted.  
  
3.12.4. Mean Alveolar Volume 
Mean alveolar volume (Valv) was measured according to the following formula: 
Valv = Lm
3
x pi/3  
Where:  
Lm = Mean linear intercept. 
 
Mean alveolar volume gives an indication of the size of the alveolus and hence the 
volume of it can contain. This means that it can be expected that alveoli with larger 
volumes has a reduced total surface area for gaseous exchange. It also implies the 
possibility of lesser alveolar surface area for gaseous exchange and because of the 
reduced number of alveoli.  
 
3.12.5. Mean Linear Intercept (Lm) 
Mean linear intercept, is the average distance between the walls of an alveolus. It is an 
index of alveolar wall size. The mean linear intercept will thus increase with an increase 
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in alveolar size such as in alveolar wall destruction. This indicates that surface area and 
mean liner intercept, are inversely related. Thus, an increase in Lm, as evidenced by 
destruction of alveolar walls is indicative of a decreased surface area available for 
gaseous exchange. 
 
Lm = N x L/m  
Where:  
N = mean number of fields counted.  
L = length of the traverses, (i.e. the cross hair length added to the vernier length, totalling 
2.02mm) 
m = the sum of all the intercepts.  
The number of alveolar intercepts (m) was counted at 100x magnification using an 
eyepiece micrometer. Approximately six points were used to determine the mean linear 
intercept per slide preparation.  
Alveolar walls that contributed to the intercept count included those that:  
 1. Touched but did not intercept the left side of the vertical line.  
 2. Touched but did not intercept the upper side of the horizontal line.  
 3. Intercepted the cross hairs.  
Cuts into and out of blood vessel walls were allocated counts of half an intercept each.  
Alveolar walls that did not contribute to the mean linear intercept included those that:  
 1. Touched without crossing the right border of the vertical arm. 
 2. Touched without crossing the lower border of the horizontal arm. 
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3.12.6. Internal Surface Area (Sa)  
The internal surface area available for gaseous exchange was measured according to the 
following formula:  
Sa = 4 x Lv/ Lm  
Where:  
Lv = lung volume.  
Lm = mean linear intercept. 
 
Statistical Analysis (Morphometry) 
Results were analysed on the “Graph Pad Instat” and “Prism” statistical analysis 
programme using standard error bars and a one-way analysis of variance test (ANOVA) 
for unpaired data and the Student-Newman Kuel’s test for pairwise comparisons. A 
probability level of P <0.05 was chosen as significant to the study. Results were recorded 
as means ± standard error of means.  
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CHAPTER 4 
 
Results 
 
4.1. The influence of Maternal Nicotine, Vitamin C and Nicotine + 
Vitamin C on Body weight and Lung volume of the offspring. 
 
 
4.1.1. Body weight (BW) 
 
The body weight (table 4.1.1. and fig 4.1(a)) of the control animals increased 
significantly (P <0.001) from 28.04 ± 2.76g on postnatal day 14 to 152.28 ± 23.63g on 
postnatal day 42. In animals exposed to nicotine during both gestation and lactation, the 
body weight also increased significantly from 19.03 ± 0.63g to 133.68 ± 5.42g (P 
<0.001). The same significance (P <0.001) was observed in the nicotine + vitamin C 
exposed animals. The increase was from 24.117 ± 1.60g to 148.08 ± 18.12g. The vitamin 
C exposed animals had an extremely significant increase, from 20.27 ± 1.10g postnatal 
day 14 to 143.39 ± 13.25g postnatal day 42. The body weight of the control animals was 
at postnatal day 14 (28.04 ± 2.76g) higher than that of the nicotine (19.03 ± 0.63g) and 
vitamin C (20.27 ± 1.10g) exposed animals (P <0.05). The body weight of the control and 
the nicotine + vitamin C exposed animals were the same (P >0.05). Also no differences in 
body weight were observed between the control and experimental animals on postnatal 
day 21 and 42 (P >0.05). 
 
 
 
 
 
 
 53 
 
 Body Weight (g±SE)  
Age Days Control Nicotine Nicotine + 
vitamin C 
Vitamin C P 
control vs. 
experiment 
14 28.04 ± 2.76 19.03 ± 0 .63* 24.12 ± 1.60 20.27 ± 1.10* P <0.05 
21 37.07 ± 1.97 31.69 ± 3.03 38.04 ± 4.81 31.81 ± 2.41 P >0.05 
42 152.28 ± 23.6 133.69 ± 5.42 148.08 ± 18.1 143.4 ± 13.23 P >0.05 
P 
   D14 vs. D42 
 
(P <0.001) 
 
(P <0.001) 
 
(P <0.001) 
 
(P <0.001) 
 
 
Table 4.1.1 Comparison of body weight for each age group of each treatment. Significant 
difference from control:*P <0.05 
 
 
 Lung volume (ml±SE)  
Age Days Control Nicotine Nicotine + 
vitamin C 
Vitamin C P 
control vs. 
experiment 
14 1.58 ± 0.08 1.36 ± 0.24 1.69 ± 0.09 1.31 ± 0.04 P >0.05 
21 1.92 ± 0.12 1.83 ± 0.23 2.07 ± 0.16 1.92 ± 0.17 P >0.05 
42 6.91 ± 0.65 5.30 ± 0.48 5.56 ± 0.25 5.99 ± 0.36 P >0.05 
P 
   D14 vs. D42 
 
(P <0.001) 
 
(P <0.001) 
 
(P <0.05) 
 
(P <0.05) 
 
 
Table 4.1.2. Comparison of lung volume for each age group of each treatment. Significant 
difference from control:*P <0.05 
 
 
 Body weight/Lung volume (g/ml±SE)  
Age Days Control Nicotine Nicotine + 
vitamin C 
Vitamin C P 
control vs. 
experiment 
14 17.83 ± 1.43 14.02 ± 0.71 14.27 ± 0.56 15.51 ± 0.71 P >0.05 
21 19.41 ± 0.96 16.88 ± 1.41 18.2 ± 1.62 16.73 ± 0.96 P >0.05 
42 25.37 ± 1.82 25.92 ± 2.72 26.49 ± 2.66 23.17 ± 1.56 P >0.05 
P 
   D14 vs. D42 
 
(P <0.001) 
 
(P <0.001) 
 
(P <0.001) 
 
(P <0.001) 
 
 
Table 4.1.3. Comparison of body weight/lung volume ratio for each age group of each treatment. 
Significant difference from control:*P <0.05 
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Fig.4.1 (a, b and c). The effect of maternal exposure to nicotine, vitamin C and a 
combination of nicotine and vitamin C on Body weight (BW), lung volume (Lv), and 
BW/Lv of the lungs of the offspring. 
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The data summarized in table 4.1.4 shows that the body weight of the control animals 
increased by 9.03 ± 0.79 g/week from postnatal day 14 to 21. However, it is interesting to 
note that between postnatal day 21 and 42 the body weight of the control animals 
increased by 46.4 ± 7.22 g/week. This increase in body weight per week after weaning is 
more than 40% faster than before weaning (P <0.001). For the nicotine exposed animals 
the increase in body weight between postnatal days 14 to 21 and 21 to 42 was 11.655 ± 
2.4 and 34.33 ± 0.79 g/week respectively. This means that before weaning the increase in 
body weight of the control and nicotine exposed animals were no different. On the other 
hand, after weaning the increase in body weight of the nicotine exposed rat pups was 
12.07 ± 2.5 g/week slower (P <0.05) than that of the control animals. 
 
 The rat pups exposed to vitamin C via the mothers’ blood and milk increased by 11.54 ± 
1.31 g/week from postnatal day 14 to 21. Between postnatal days 21 to 42 the body 
weight increased by 37.19 ± 3.61/week. The nicotine + vitamin C exposed animals’ body 
weight increased by 13.92 ± 3.21 g/week from postnatal day 14 to 21; and by 36.68  ± 
4.43 g/week between postnatal days 21 to 42. As for the control animals the increase in 
body weight between postnatal day 14 and 21, of the rats that were exposed to nicotine, 
or vitamin C, or nicotine + vitamin C during gestation and lactation, were slower than 
that between postnatal days 21 to 42. It is also interesting to note that the body weight of 
all the groups that received vitamin C, or a combination thereof, like the rats that were 
exposed to nicotine, increases slower (P <0.05) than the control between postnatal day 21 
and 42.  
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Age Days Control Nicotine Vitamin C Nicotine + 
Vitamin C 
P 
control vs. 
experiment 
14-21 9.03 ± 0.79 11.6 ± 2.4 11.54 ± 1.31 13.92 ± 3.21 P >0.05 
21-42 46.4 ± 7.22 34.3 ± 0.79* 37.19 ± 3.61* 36.68 ± 4.43* P <0.05 
P 
   D14-21 
    vs. 
   D21-42 
 
 
(P <0.001) 
 
 
(P <0.001) 
 
 
(P <0.001) 
 
 
(P <0.001) 
 
 
Table 4.1.4 Body weight increase of the animals per week (g/week), between postnatal day 14 to 
21 and postnatal day 21 to 42. Significant difference from control: *P <0.05 
 
 
4.1.2. Lung volume  
 
The lung volumes (table 4.1.2 and fig. 4.1(b)) of the control and nicotine exposed rat 
pups increased more than four and three-fold respectively from 1.58 ± 0.08 ml on 
postnatal day 14 to 6.91 ± 0.65 ml on postnatal day 42 (P <0.001) for the control rats and 
the nicotine exposed animals from 1.36 ± 0.24 ml to 5.30 ± 0.45 ml (P <0.001). The lung 
volume of the vitamin C exposed animals increased more than four-fold from 1.3 ± 0.04 
ml to 5.9 ± 0.36 ml postnatal day 42, while that of the nicotine + vitamin C exposed 
animals increased more than three-fold from 1.69 ± 0.09 ml to 5.5 ± 0.25 ml postnatal 
day 42 (P<0.05). No significant difference in lung volume was observed between the 
control and experimental animals (P >0.05). The BW/Lv ratios were also not affected by 
maternal nicotine exposure (table 4.1.3 and fig. 4.1(c)). 
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Changes in lung volume in the animals showed that in control animals, the lung volume 
increased by 0.35 ± 0.04 ml/week between postnatal day 14 and 21, and postnatal day 21 
and 42 by 1.66 ± 0.18 ml/week (P <0.01). In contrast to that of the control rats, the 
increase in the lung volumes of the rats that were exposed to nicotine via the placenta and 
mother’s milk between postnatal days 14 and 21 (0.47 ± 0.01 ml/week) was not different 
(P>0.05) than the increase between postnatal days 21 and 42 (0.47 ± 0.08 ml/week). The 
lung volume of the animals exposed to vitamin C only increased by 0.61 ± 0.13 ml/week 
from postnatal day 14 to 21, and between days 21 to 42 the lung volume increased by 
1.36 ± 0.06 ml/week; and the lung volume of those rats exposed to both nicotine + 
vitamin C the lung volume increased by 0.38 ± 0.07 ml/week from postnatal day 14 to 21 
and by 1.16 ± 0.03 ml/week between postnatal day 21 to 42 (P <0.01).  
 
 
Age Days Control Nicotine Vitamin C Nicotine + 
Vitamin C 
P 
control vs. 
experiment 
14-21 0.35 ± 0.04 0.47 ± 0.01 0.61 ± 0.13* 0.38 ± 0.07 P <0.05 
21-42 1.66 ± 0.18 0.47 ± 0.08* 1.36 ± 0.06 1.16 ± 0.03 P <0.05 
P 
   D14-21 
    vs. 
   D21-42 
 
 
(P <0.01) 
 
 
(P >0.05) 
 
 
(P <0.01) 
 
 
(P <0.01) 
 
 
Table 4.1.5.  Lung volume increase of the animals per week (ml/week), between postnatal day 14 
to 21 and postnatal day 21 to 42. Significant difference from control: *P <0.05 
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4.2 The influence of Maternal exposure to nicotine, vitamin C, or 
nicotine + vitamin C on the volume density of the airspaces and 
paranchymal tissue of the off spring. 
 
            
4.2.1 Volume density of air (Va) and paranchymal tissue density (Vt)   
 
The Va and Vt (table 4.2 and fig 4.7 a and b) of the control animals remain constant 
between postnatal days 14 (Va: 76.13 ± 1.87 and Vt: 23.88 ± 1.87) and 42 (Va: 77 ± 0.87 
and Vt: 23 ± 0.87). On the other hand, the Va of the nicotine exposed animals (85.78 ± 
0.61) of the day 14 rat pups is higher than that of the control (P <0.01), but decreases as 
the animal ages to 81.43 ± 0.33 on postnatal day 42. As a result of this decrease the Va on 
postnatal day 42 is not different (P >0.05) from that of the control animals of the same 
age. This implies that the paranchymal tissue density on day 14 of the nicotine exposed 
pups was lower (P<0.01) than that of the control rats of the same age but resembles that 
of the control on day 42. The Va and Vt of the lungs of the rat pups exposed to vitamin C 
only or to both nicotine and vitamin C were not different from that of those rat pups that 
were exposed to nicotine only via the placenta and mother’s milk. There was also no 
significant difference (P >0.05) in the Va and Vt of the rat pups exposed to vitamin C only 
or to both nicotine and vitamin C from that of the control animals.  
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Fig.4.2 (a and b). The effect of maternal exposure to nicotine, vitamin C and a combination of 
nicotine and vitamin C on the Tissue and alveolar air volume of the offspring. 
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4.3 Internal Surface area and Mean Liner Intercepts 
 
4.3.1. Internal Surface area (Sa)  
 
Table 4.3.1 and fig 4.3.  indicates that the Sa of the control animals increased from 150.12 
± 10.16 cm2 on postnatal day 14 to 584.53 ± 40.24 cm2 on postnatal 42 (P <0.001). 
Similar observations were made with the other groups. That is, the Sa of the nicotine 
exposed animals increased from 139.62 ± 3.86 cm2 on postnatal day 14 to 410.13 ± 30.78 
cm2 on postnatal day 42 (P <0.001); the Sa of the nicotine + vitamin C exposed animals 
increased from 145.31 ± 10.42 cm2 on postnatal day 14 to 490.71 ± 21.11 cm2 on 
postnatal day 42 (P <0.001) and the Sa of the vitamin C exposed animals increased from 
135.98 ± 10.41 cm2 on postnatal day 14 to 501.12 ± 13.26 cm2 on postnatal day 42 (P 
<0.001).  
 
The increase in the Sa  of the nicotine and vitamin C exposed rats was at 26.05 ± 4.02 and 
22.56  ± 4.01 cm2/week respectively, slower (P>0.05) than the 29.09 ± 4.51 and 30.88 ± 
5.68 cm2/week of the control rats and those that received both nicotine and vitamin C. 
This trend is maintained between postnatal days 21 and 42 where the increase in Sa  of the 
nicotine exposed rats was at 81.66 ± 6.65 and that of the vitamin C group at 112.02 ± 
7.24 cm2/week as oppose to the 140.77 ± 19.19 and 137.61± 18.33 cm2/week of the 
vitamin C group. The increase in the Sa of the nicotine group during this phase of lung 
growth was also slower (P< 0.05) than that of the vitamin C group. 
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The increase in the Sa (fig. 4.3) of the various groups follows the same trend as the 
increase in body weight of the rats (fig. 4.1.1). 
 
 
 Internal surface area (cm2±SE)  
Age Days Control Nicotine Nicotine + 
vitamin C 
Vitamin C P 
control vs. 
experiment 
14 150.12 ± 10.16 139.62 ± 6.86* 145.31 ± 10.24 135.98 ± 7.41* P <0.05 
21 179.21 ± 18.65 165.67 ± 12.31 167.87 ± 16.53 171.86 ± 13.93 P >0.05 
42 584.53 ± 40.24 410.13 ± 30.78* 490.71 ± 21.11 501.12 ± 26.26 P <0.05 
P 
 D14 vs. D42 
 
(P <0.001) 
 
(P <0.001) 
 
(P <0.001) 
 
(P <0.001) 
 
 
Table 4.3.1. Comparison of internal surface area for each age group of each treatment .Significant 
difference from control:*P <0.05 
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Fig.4.3. The influence of maternal exposure to nicotine, vitamin C and a combination of nicotine 
and vitamin C on the internal surface area (Sa) of the lungs of the offspring 
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The Sa/Lv ratio of the nicotine exposed animals (70.32 ± 4.63 cm2/ml)2) was 24% less (P 
<0.001) than that of the control animals (92.74 ± 3.35 (cm2/ml)2) at postnatal day 14. The 
animals exposed to vitamin C only had a Sa/Lv ratio of 70.93 ± 4.12 cm2/ml)2, which was 
22% smaller (P <0.01) than the control animals. At postnatal day 14 there was no 
significant difference between the animals that were both exposed to nicotine and vitamin 
C (85.96 ± 4.08 cm2/ml)2) to the control animals (P >0.05). It is also noticed that at 
postnatal day 14 the animals exposed both to nicotine and vitamin C, the Sa/Lv ratio was 
17% higher (P <0.01) than that of the nicotine exposed animals. At postnatal days 21 and 
42 there was no difference (P >0.05) between all of the experimental groups. 
 
 
Age Days Control Nicotine Vitamin C Nicotine + 
Vitamin C 
P 
control vs. 
experiment 
14-21 29.09 ± 4.51 26.05 ± 4.02* 22.56 ± 4.01* 30.88 ± 5.68 P <0.05 
21-42 140.77 ± 19.19 81.66 ± 6.15* 112.02 ± 7.24* 137.61 ± 18.33 P <0.05 
P 
   D14-21 
    vs. 
       D21-42 
 
 
(P <0.05) 
 
 
(P <0.05) 
 
 
(P <0.05) 
 
 
(P <0.05) 
 
 
Table 4.3.2  Internal surface area changes of the lungs of the animals per week (cm2/week), 
between postnatal day 14 to 21 and postnatal day 21 to 42. Significant difference from control: *P 
<0.05 
 
4.3.2. Mean Linear Intercepts (Lm)  
 
The mean linear intercepts of all the experimental animals are summarized in table 4.3.3 
and fig. 4.3.2. No significant differences were observed in any of the groups. The Lm of 
the control animals increased from 42.5 ± 1.82 µm on postnatal day 14 to 45.5 ± 0.96 µm 
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on postnatal 42 (P <0.05). On the other hand the mean linear intercepts of the nicotine 
exposed animals decreased from 56.33±0.67 µm on postnatal day 14 to 50 ± 1.65 µm on 
postnatal day 42 (P <0.05). The mean linear intercepts of the animals exposed to both 
nicotine and vitamin C also decreased from 48 ± 2.04 µm on postnatal day 14 to 45.3 ± 
2.02 µm on postnatal day 42 (P <0.05). The mean linear intercepts of the vitamin C only 
exposed animals decreased from 52.25 ± 0.25 µm on postnatal day 14 to 50 ± 2.48 µm on 
postnatal day 42 (P >0.05). This means that the Lm of those animals that were exposed to 
a combination of nicotine and vitamin C decreased by 5.9 % as oppose to the 4.5 % of 
animals that were exposed to vitamin C only and the 12.6 % of those exposed to only 
nicotine. 
 
 
 Mean linear intercepts (µm3x104±SE)  
Age Days Control Nicotine Nicotine + 
vitamin C 
Vitamin C P 
control vs. 
experiment 
14 42.5 ± 1.82 56.33 ± 0.67* 48 ± 2.04* 52.3 ± 0.25* P <0.001 
21 43.75 ± 1.25 53.5 ± 0.96* 47 ± 1.08 53 ± 0.81* P <0.001 
42 45 ± 0.96 50 ± 1.65* 45.3 ± 2.02 50 ± 2.48* P <0.05 
P 
D14 vs. D42 
 
(P <0.05) 
 
(P <0.05) 
 
(P <0.05) 
 
(P <0.05) 
 
 
Table 4.3.3. Comparison of mean linear intercepts for each age group of each treatment. 
Significant difference from control:*P <0.05 
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Fig.4.3.2. The influence of maternal exposure to nicotine, vitamin C and a combination of 
nicotine and vitamin C on the linear intercept of the lungs of the offspring. 
 
The mean linear intercepts of the nicotine (56.33 ± 0.67µm) and vitamin C only exposed 
rats (52.25 ± 0.25 µm) was 25% and 19% respectively higher (P <0.001) than the control 
animals (42.5 ± 1.82µm) at postnatal day 14 and 21. No significant difference is seen 
when comparing the control animals and the nicotine + vitamin C exposed animals (P 
>0.05) at postnatal day 21 and 42.  
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4.4 Alveolar Volume and Alveolar Number  
 
4.4.1. Alveolar Volume (Valv)   
 
The data summarized in table 4.4.1 and illustrated in fig. 4.4.1 show that the Valv of the 
control animals remain unchanged between days 14 and 42. On the other hand, those 
animals that were exposed to nicotine showed a decrease (P <0.05) in Valv between 
postnatal days 14 to 42. From the data it is also clear that the Valv of the control animals 
for all the age groups was smaller than that of the animals exposed to only nicotine, or 
only vitamin C. The Valv of those that were exposed to a combination of nicotine + 
vitamin C was not different from that of the control animals. The alveolar volume of the 
nicotine exposed animals at postnatal day 14 was at 18.74 ± 0.66 x 104 µL, 56.4% higher 
(P <0.001) than the 8.18 ± 1.04 x 104 µL of the control animals. From postnatal day 14  to 
postnatal day 42 the alveolar volume of the nicotine exposed animals gradually decreased 
to 14.23 ± 1.38 x 104 µL, where the latter was 30.4% higher (P <0.001) than the 9.90 ± 
0.61 x 104 µL of the control animals. The alveolar volume of the animals exposed to the 
combination of nicotine and vitamin C at postnatal day 14 and 21 was 11.77 ± 1.48 x 104 
µL and 10.92 ± 0.77 x 104 µL respectively, 37 % and 32 % respectively lower (P <0.01) 
than that of the nicotine animals. Calculations show that the alveolar volume of the 
animals exposed to only vitamin C was (14.94 ± 0.22 x 104 µL) 45.2% higher (P <0.01) 
than the 8.18 ± 1.04 x 104 µL of the control animals. At postnatal day 21 the alveolar 
volume of the vitamin C animals was at 15.62 ± 0.72 x 104 µL, 43.5% higher (P <0.001) 
than the 8.83.3 ± 0.76 x 104 µL of the control animals. At postnatal day 42 the alveolar 
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volume of the animals exposed to nicotine only, vitamin C only, or to both  nicotine + 
vitamin C was the same (P >0.05). 
 
 
 
 Mean alveolar volume (µm3x104±SE)  
Age Days Control Nicotine Nicotine + 
vitamin C 
Vitamin C P 
control vs. 
experiment 
14 8.18±1.04 18.74 ± 0.66* 11.77 ±1.48 14.94 ± 0.2* P <0.001 
21 8.83±0.76 16.08 ± 0.85* 10.92 ± 0.77 15.62 ± 0.7* P <0.001 
42 9.90±0.61 14.23 ± 1.38* 9.86 ± 1.20 13.38 ± 1.9* P <0.001 
P  
D14 vs. D42 
 
(P >0.05) 
 
(P <0.05) 
 
(P >0.05) 
 
(P >0.05) 
 
 
Table 4.4.1. Comparison of mean alveolar volume for each age group of each treatment. 
Significant difference from control:*P <0.05 
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Fig.4.4.1. The influence of maternal exposure to nicotine, vitamin C and a combination of 
nicotine and vitamin C on the alveolar volume (Valv) of the offspring. 
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4.4.2. Alveolar Number   
  
Table 4.4.3 and fig. 4.4.2 shows that on postnatal day 14 the alveolar number of the lungs 
of the control animals was 2.54 ± 0.55 million, which is 62% higher (P <0.05) than the 
0.97 ± 0.11 million of the nicotine exposed animals and 64% higher (P <0.05) than the 
0.98 ± 0.11 million of the vitamin C exposed animals. The alveolar number of the 
animals that were exposed to a combination of nicotine and vitamin C was, however, the 
same as for the control animals at postnatal day 14. On day 21 after birth the alveolar 
number of the control rats and those exposed to both nicotine and vitamin C was not 
different, but that of the other two groups were lower (P <0.05). At postnatal day 42 the 
alveolar number of the lungs of the control animals was at 3.97 ± 1.09 million, 56.45% 
higher (P <0.01) than the 1.73 ± 2.07 million of the nicotine exposed animals. Even 
though the alveolar number of the nicotine exposed animals and rat pups exposed to 
vitamin C was the same at postnatal day 14 and 21, the alveolar number of rats exposed 
to both nicotine and vitamin was (2.16 ± 1.82 million) 34% higher (P <0.05) than that of 
the rats exposed to nicotine only. The alveolar number of the 42-day-old rats that were 
exposed to vitamin C only was the same (P >0.05) as that of the animals exposed to both 
nicotine and vitamin C. 
 
Fig 4.4.3 and table 4.4.5 shows that the alveolar number/body weight ratio of the control, 
nicotine and vitamin C exposed animals were significantly different on postnatal days 14 
and postnatal day 42 (P <0.05). Like the alveolar number/body weight ratio, the alveolar 
number/surface area ratio of the control, nicotine and vitamin C exposed animals were 
significantly different on postnatal day 14 and postnatal day 42 (P <0.05).  
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 Alveolar number (x106±SE)  
Age Days Control Nicotine Nicotine + 
vitamin C 
Vitamin C P 
control vs. 
experiment 
14 2.54 ± 0.55 0.97 ± 0.11* 2.05 ± 0.21 0.98 ± 0.11* P <0.05 
21 3.29 ± 0.55 1.91 ± 0.56* 3.27 ± 0.42 1.97 ± 0.40* P <0.05 
42 3.97 ± 1.09 1.73 ± 2.07* 2.16 ± 1.82* 2.29 ± 2.76* P <0.01 
P 
D14 vs. D42 
 
(P <0.05) 
 
(P <0.05) 
 
(P <0.05) 
 
(P <0.05) 
 
 
Table 4.4.3. Comparison of alveolar number for each age group of each treatment. Significant 
difference from control:*P <0.05 
 
 Alveolar number/Surface area (x106/cm2±SE)-4  
Age Days Control Nicotine Nicotine + 
vitamin C 
Vitamin C P 
control vs. 
experiment 
14 1.67 ± 0.23 1.04 ± 0.09* 1.43 ± 0.09 0.98 ± 0.05* P <0.05 
21 1.88 ± 0.17 1.29 ± 0.21 1.85 ± 0.1 1.32 ± 0.15 P >0.05 
42 6.20 ± 0.83 4.18 ± 0.26* 5.31 ± 0.29 4.54 ± 0.39* P <0.05 
P 
D14 vs. D42 
 
(P <0.05) 
 
(P <0.05) 
 
(P <0.05) 
 
(P <0.05) 
 
 
Table 4.4.4. Comparison of alveolar number/surface area ratio for each age group of each 
treatment. Significant difference from control:*P <0.05 
 
 Alveolar number/body weight (x106/g±SE)  
Age Days Control Nicotine Nicotine + 
vitamin C 
Vitamin C P 
control vs. 
experiment 
14 0.91 ± 0.2 0.51 ± 0.04* 0.89 ± 0.1 0.49 ± 0.4* P <0.05 
21 0.89 ± 0.1 0.61 ± 0.04 0.89 ± 0.1 0.61 ± 0.03 P >0.05 
42 2.18 ± 0.3 1.30 ± 0.1* 1.83 ± 0.2 1.59 ± 0.2* P <0.05 
P 
D14 vs. D42 
 
(P <0.05) 
 
(P <0.05) 
 
(P <0.05) 
 
(P <0.05) 
 
 
Table 4.4.5. Comparison of alveolar number/body weight ratio for each age group of each 
treatment. Significant difference from control:*P <0.05 
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Fig.4.4.2 (a and b). The influence of maternal exposure to nicotine, vitamin C or a combination of 
nicotine and vitamin C on the alveolar number (Na) and, alveolar number/ internal surface area 
(Sa) of the lungs of the offspring.  
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Fig.4.4.3. The influence of maternal exposure to nicotine, vitamin C and a combination of 
nicotine and vitamin C on the alveolar number (Na)/ BW ratio of the offspring. 
 
 
The alveolar number in the control animals increased by 0.75 ± 0.1 million /week 
between postnatal days 14 and 21 and between postnatal days 21 and 42 by 0.36 ± 0.18 
million /week. The alveolar number of the nicotine exposed animals increased between 
postnatal day 14 to 21 and 21 to 42 by 0.94 ± 0.45 million and 0.51 ± 0.50 million /week 
respectively. During the same period of time the alveolar number of the experimental 
animals exposed to vitamin C only increased by 0.9 ± 0.29 million /week from postnatal 
day 14 to 21; and between days 21 to 42 the alveolar number increased by 0.69 ± 0.79 
million /week. The nicotine + vitamin C exposed animals alveolar number increased by 
1.23 ± 0.21 million /week from postnatal day 14 to 21; and by 0.76 ± 0.47 million /week 
between postnatal day 21 to 42.  
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Age Days Control Nicotine Vitamin C Nicotine + 
Vitamin C 
P 
control vs. 
experiment 
14-21 0.75 ± 0.1 0.94 ± 0.45 0.9 ± 0.29 1.23 ± 0.21* P <0.05 
21-42 0.36 ± 0.18 0.51 ± 0.50 0.69 ± 0.79 0.76 ± 0.47* P <0.05 
P 
   D14-21 
    vs. 
     D21-42 
 
 
( P <0.05) 
 
 
( P <0.05) 
 
 
( P <0.05) 
 
 
( P <0.05) 
 
 
 
Table 4.4.6.  Alveolar number increase of the animals per week (million /week), between 
postnatal day 14 to 21 and postnatal day 21 to 42. Significant difference from control: *P <0.05 
 
 
 4.5. Morphology Results 
 
 
Figure 4.5 is light micrographs that illustrate structural differences between control 
animals (A); nicotine exposed animals (B) and combination of nicotine + vitamin C 
exposed animals (C) at postnatal day 42. Evaluations of the (B) and (C) light 
micrographs, the alveolar appear larger and in many areas the septae are missing. The 
enlarged air sacs that occur in light micrograph (B) resembles emphysematous lesions 
and the structural disturbances seen on light micrograph (C) seem to resemble senile 
emphysema. The control lung (light micrograph (A)) appears normal. 
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Fig.4.5.1. Lung tissue of 42-day-old control rats (A) and rats exposed to nicotine (B), vitamin C 
(C), and a combination of nicotine and vitamin C (D) via the placenta and mother’s milk during 
gestation and lactation where ME indicate some of the enlarged alveoli characteristic of 
microscopic emphysema. (Bar= 0.5 µm) 
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Fig.4.5.2. Elastic tissue of lungs of 42-day-old A) control rats, and rats exposed to B) nicotine, C) 
vitamin C, and D) a combination of nicotine and vitamin C via the placenta and mother’s milk 
during gestation and lactation., Red arrows = breaks in elastic tissue strands.                                                                     
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CHAPTER 5 
 
 Discussion of results 
 
 
5.1. Maternal nicotine exposure and the development of the neonatal rat lung 
as a gas exchanger 
 
Studies by Barker (1996) suggested that certain adult onset diseases may result from 
changes in the in utero environment prior to birth. These diseases have been associated 
with foetal growth reflected as small size for age. These diseases include high blood 
pressure, diabetes mellitus and others (Barker et al, 1996). Where most of the previous 
studies dealt with nutrition and growth and the link with foetal onset of adult diseases, 
recent research showed that certain lifestyle factors, such as smoking and exposure to 
nicotine also affect lung development and growth (Maritz, 2008). It is suggested that 
these changes in lung growth and development induced by changes in the in utero 
environment may have long term consequences in terms of respiratory health (Li et al, 
2000). Changes that were observed include impaired glucose metabolism (Maritz, 1992) 
as well as structural changes (Maritz et al, 2003). It is interesting to note that most of 
these changes occur after nicotine withdrawal (Maritz and Windvogel, 2005). Adequate 
nutrition is essential for foetal and neonatal development as it supplies energy and 
precursors, such as amino acids, to support growth. Inadequate nutrition supply will 
therefore result in stunted foetal and neonatal growth, and will result in newborns that are 
small for their age. It is suggested that poor foetal nutrition not only results in a smaller 
body size, but also results in foetal adaptations that ‘programme’ future propensity to 
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adult disease (Lucas et al. 1999). Smoking is associated with constriction of the blood 
vessels that transport nutrients to the developing foetus. It is, therefore, suggested that the 
lower body weights of babies born from smoking mothers is due to a lower nutrient 
supply (Davies and Albertiny, 1976). In the current study it was shown that maternal 
nicotine exposure during gestation and lactation resulted in lower body weight at 
postnatal day 14. However, due to catch-up growth between postnatal days 14 and 21, the 
body weight of the 21-day-old nicotine exposed rats were not different from that of the 
control rats of the same age. The lower body weight at postnatal day 14 and thus at birth 
can in all likelihood be attributed to an inadequate nutrient supply from the mother’s 
blood. Once the intake of nicotine decreases as the animals grow older and are more 
dependent on solid food than mother’s milk, the growth rate increases. Although no 
direct evidence exists to support this, it is possible that nicotine or a product of nicotine 
metabolism also suppressed growth in a reversible manner. At least two authors (Chung-
Ming, 2005 and Jordanov, 1990) have shown that nicotine accumulates in the developing 
lung and that its concentration in the amniotic fluid is higher than in the mother’s blood. 
This means that nicotine, with its oxidant effect, is present in the developing lung which 
may induce changes in the events that control lung growth, development and aging. 
 
It is also very important to note that in the current study the rat pups began to eat solid 
food from postnatal day 12, which is towards the end of the phase of rapid 
alveolarisation. As the animals grew older they ate more solid food and the milk intake 
gradually decreased and thus also the intake of nicotine via the mothers milk up to 
postnatal day 21 when they were weaned. The half life of nicotine is about 90 minutes 
 
 
 
 
 77 
 
(Russell and Feyerabend, 1978); therefore it is conceivable that the nicotine will be 
quickly eliminated from the tissue of the neonates after weaning.  It is therefore unlikely 
that changes in lung structure and metabolism that occur after weaning can be attributed 
to a lack of nutrients or to the presence of nicotine in the tissue of the offspring. Taking 
these observations into account, it is conceivable that the changes in lung structure 
reported in this study, and that occur after weaning on postnatal day 21, is due to changes 
in the factors that controls lung development, maintenance of lung integrity and aging. 
 
In order for the lung to operate effectively as an organ of gas exchange at birth, the lung 
must have developed a large internal surface area. This is achieved by the formation of 
millions of thin-walled alveoli, as well as a dense capillary network to ensure proper gas 
exchange between blood and alveolar air (Harding and Hooper, 1993). Any interference 
with lung growth may render the lungs less effective as a gas-exchanger and even more 
susceptible to respiratory disease in later life (Landau, 2006). It has also been well 
demonstrated that elastic tissue formation by the fibroblast in the alveolar septa plays an 
important role in alveolarisation (Emery, 1970). Since lung structure and function is 
closely associated, changes in lung structure will result in compromised respiratory 
function. The connective tissue framework of the lung plays an important role in 
maintaining lung structure and function. It also plays an important role in lung 
development and in particular alveolar formation (Burri, 2006). Elastic tissue in 
particular plays an important role in normal breathing by maintaining lung compliance 
(Thibeault, 1999). Damage to the connective tissue framework of the lung will thus result 
in compromised lung function. It is therefore important to ensure that lung development 
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in utero as well as after birth is maintained to ensure normal lung function and resistance 
to disease. This includes adequate nutrition and to refrain from a lifestyle, such as 
smoking or nicotine replacement, that might compromise the in utero environment where 
foetal development occurs. 
 
The data from the current study demonstrated that the proportion of alveolar air in the 
nicotine-exposed offspring was higher at postnatal day 14 than that of the control group. 
This implies that the volume density of the parenchymal tissue of the 14-day-old nicotine 
exposed pups was lower than that of the control rats of the same age. However, by day 42  
after birth no significant difference were seen in the air and tissue densities in the rat pups 
exposed to nicotine or to vitamin C only, or to a combination of nicotine and vitamin C. 
This means that after weaning and thus from the onset of nicotine withdrawal, the volume 
density of the lung parenchyma of the nicotine rats returned to a level that resembles that 
of the control animals. It is imperative to note that the volume density of the tissue of the 
14-day-old rats that were exposed to both nicotine and vitamin C was the same as for the 
control animals. This indicates that maternal vitamin C supplementation during gestation 
and lactation prevented the effect of maternal nicotine exposure on the tissue densities of 
the lungs of the offspring.  
 
The lung is predetermined to develop a gas exchanger area with enough reserve capacity 
which can provide an adequate supply of oxygen to the organism and thus to satisfy the 
energy demands of the body, even during strenuous exercise conditions. The surface area 
for gas exchange increases as the animal grows by the formation of new alveoli through 
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septation (Burri, 1974). Any interference with the process of alveolar development during 
foetal and neonatal phases of lung development may therefore reduce the area available 
for gas-exchange and thus the capacity of the lung to meet an increase in oxygen demand. 
It is important to note that the internal surface area and alveolar number of the 14 day-old 
nicotine-exposed rat pups were lower than that of the control animals despite the fact that 
the lung volume was not affected by maternal nicotine exposure. This means that the 
alveolar volume of the lungs of the rats that were exposed to nicotine via the placenta and 
mother’s milk must be larger than that of the other groups. The data in this study indeed 
show that the mean alveolar volume of the nicotine exposed rats of the same age was 
larger than that of the control animals. 
 
 The internal surface area of the nicotine–exposed animals was the same as that of the 
controls at postnatal day 21. This implies that maternal nicotine exposure had no 
influence on the formation of the secondary septa during the phase of lung development 
that follows the phase of rapid alveolarisation. On the other hand, at postnatal day 42, the 
alveolar number was smaller than that of the control animals of the same age. In addition, 
the alveolar volume was larger than that of the control rats. It is, therefore, not surprising 
that the internal surface area of the nicotine exposed rat pups was lower than that of the 
control animals of the same age. It is interesting to note that when the alveolar number is 
corrected for body weight, the alveolar number/body weight ratio of the nicotine exposed 
animals was lower than that of the control animals. This means that alveolar formation 
after weaning was slower than the increase in body weight as the animals mature. It is 
also plausible that it was due to a slow degradation of the lung parenchyma over time. As 
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a consequence the increase in alveolar number and thus internal surface area was not 
proportional to the increase in body weight. Following on that the alveolar surface area 
available for gas exchange of the lungs of the nicotine exposed rat pups was lower than 
that of the control animals and consequently also the reserve capacity. This is supported 
by the morphological data which show signs of emphysema at postnatal day 42. This is 
further supported by the lower alveolar number/internal surface area ratio of the nicotine 
exposed animals compared to that of the controls because the rate of alveolar number 
increase in the controls exceeded that of the nicotine exposed animals while at the same 
time the alveolar volume of the control animals remained smaller than that of the nicotine 
exposed animals. 
 
In neonatal rat lung, fibroblast elastin expression peaks during the second postnatal week, 
that is during the phase of rapid alveolarization, and declines rapidly thereafter (Noguchi 
and Samaha, 1991). This signify that interference with lung fibroblast integrity at this 
stage of lung development may result in impaired lung growth and development, this is 
of significance especially since elastin is associated with the development of alveoli 
(Kehan, 2005) and thus with the development of the internal surface area for gas 
exchange to meet the demands of the body for oxygen during resting as well as exercise 
conditions. The importance of the fibroblasts in maintaining lung structure and function 
is also demonstrated by the fact that lung fibroblasts from patients with emphysema show 
a reduced proliferation rate and premature aging which is characterised by slow 
degeneration of the lung parenchyma (Holz, et al, 2004; Miller and Welker, 2006; 
Verbeken, et al, 1992). As a consequence the capacity of the lung as gas-exchanger 
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decreased. It is therefore plausible that the reduced lung internal surface area of the 42-
day-old nicotine exposed offspring was due to an inability of the lung fibroblasts to 
maintain the structural integrity of the lungs, in all likelihood due to premature aging of 
the fibroblast (Miller and Welker, 2006). This is attributed to altered “programming” due 
to the changes in the in utero environment that the developing lungs were exposed to 
(Maritz and Windvogel, 2005). The reason for the altered “programming” is not clear, but 
it has been shown that oxidants and nicotine can induce point mutations in DNA 
(Kleinsasser, Sassen, Semmler et al, 2005). This is done by the direct effect of nicotine, 
by a slower flux of glucose through the glycolytic pathway and by an oxidant/anti-
oxidant imbalance, which may all change the “program” that controls lung development 
and aging (Maritz et al, 2008). The latter can be attributed to the fact that nicotine 
induces peroxidation of membrane lipids (Kalpana and Menon, 2004).  
 
Since the internal surface area of the current control and nicotine–exposed animals were 
the same on postnatal day 21, it implies that the effect of maternal nicotine exposure on 
alveolar formation and maturation was exerted mostly during the phase of equilibrated 
growth of the lung and after nicotine was removed from the lungs by the normal 
metabolic processes. It has been reported that between postnatal days 14 and 21, just after 
the phase of rapid alveolarisation, which ends on postnatal day 13, the number of 
fibroblast in the lung parenchyma decreases (Burri et al, 1974). This decrease in 
fibroblast occurs by means of programmed cell death or apoptosis, which peaks between 
postnatal days 17 and 19 (Bruce, 1999). The decrease in fibroblast numbers can be 
attributed to the normal development processes associated with the slower rate of alveolar 
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formation that followed the earlier rapid phase of alveolar formation. Fewer fibroblasts 
are thus required to meet the demands of the lung at this stage of growth and 
development. 
 
Apoptosis of fibroblasts in the alveolar walls also plays a key role in thinning of the 
alveolar septa that occurs after the phase of rapid alveolarisation (Schinttny et al, 1998). 
The rate of apoptosis after alveolarisation increases owing to a decrease in the Bcl-2 and 
an increase in BAX in the fibroblast on postnatal day 16 (Yang et al, 1995). Nicotine 
activates mitogen-activated protein (MAP) kinase signalling pathway, specifically 
extracellular signalling-regulated kinase (ERK2), resulting in an increased expression of 
Bcl-2 protein and inhibition of apoptosis (Heusch and Maneckjee, 1998). Thus, while the 
animals were exposed to nicotine it could, via this signalling pathway, suppress apoptosis 
and consequently slow apoptosis and thus slower thinning of the alveolar walls. It is 
probable that the role of this signalling pathway in the control of apoptosis will be the 
same in the fibroblast of the lungs of the offspring after 21 days of nicotine withdrawal 
since the half life of nicotine is only about 90 minutes, unless the program that controls 
expression of these proteins were changed by nicotine during gestation and lactation. 
This is possible because nicotine can cause point mutations in DNA (kleinsasser et al, 
2005). It is also likely that if the fibroblast of the nicotine exposed lungs age faster than in 
control lung, that it may enhance apoptosis in these cells. The morphometric and 
morphologic data from this study show that the lungs of the 42-day-old nicotine exposed 
animals developed emphysema-like lesions. Although no direct evidence is available to 
support this, it is plausible that nicotine inhibited the proliferation of the lung fibroblast 
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and fibroblast-mediated responses and therefore in this way contributed to the 
development of emphysema. It may also have increased the rate of apoptosis and in this 
way contributed to the induction of emphysema in this study. Studies to investigate this 
are being planned. This is plausible if nicotine changed the “program” that controls the 
signalling pathways that control apoptosis. 
 
In the current study it is apparent that fibroblast function was still adequate up to at least 
postnatal day 21. Since the emphysema-like lesions only developed after nicotine 
withdrawal on postnatal day 21, it is conceivable that the fibroblast proliferation rate, as 
well as fibroblast-mediated response may be compromised at a younger age than the 
average. If this is so it may explain the early development of the emphysema-like lesions 
that was observed in the lungs of the 42-day-old nicotine exposed rats. It is also possible 
that maternal nicotine exposure during gestation and lactation, and thus the exposure of 
the developing lung to nicotine levels that is higher than that in the mother’s blood 
(Jordanov, 1990), induced changes in the “program” that control fibroblast metabolism 
and aging. If this is so, it offers a possible answer as to why maternal nicotine exposure 
rendered the lungs of the offspring more susceptible to damage and emphysema. This is 
supported by a number of studies that have shown some genes that have been candidates 
for determining the susceptibility to pulmonary emphysema (Finlay et al, 1997; Smith 
and Harrison, 1997). With regard to this, it has been reported that the disruption of the 
klotho gene resulted in the gradual development of pulmonary emphysema in mice. It is 
possible that maternal nicotine exposure changes these genes that are responsible for the 
control of lung development and the maintenance of lung integrity after birth as the lungs 
 
 
 
 
 84 
 
mature and age (Finlay et al, 1997). Furthermore, research has shown that long-term 
nicotine exposure results in a predisposition for the induction of genetic instability (Guo 
et al, 2005). Gene instability requires two critical elements, namely an inappropriate cell 
cycle progression, and DNA damage. Long-term nicotine exposure, through the 
activation of Ras pathways and up-regulating cyclin D1, disrupts the G1 arrest. It also 
augments the production of ROS which may lead to DNA damage. This implies that 
exposure to nicotine via tobacco smoking or nicotine replacement therapy to quit 
smoking will make the lungs more prone to the development of respiratory diseases, and 
an increased propensity to develop emphysema later in life even if the individual never 
smoked (Guo et al, 2005). 
 
From the above mentioned findings it can be concluded that not only smoking, but also 
nicotine replacement therapies during gestation and lactation may have an adverse effect 
on lung development in the offspring and render it more susceptible to respiratory disease 
in the long run. This implies that although no effects will be observed in the short term, 
nicotine replacement therapy, during pregnancy and lactation will have a long-term effect 
in the maintenance on lung integrity and respiratory health of the offspring.  
 
5.2. Maternal vitamin C supplementation during maternal nicotine exposure  
Apart from being an important anti-oxidant, vitamin C (ascorbic acid) is essential for 
collagen formation. Vitamin C is a co-factor for hydroxylases and mono-oxygenase 
enzymes involved in the synthesis of collagen (McGowan et al, 1984). Because 
subcutaneous administration of nicotine reduces the vitamin C content of adult rat lung 
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(Maritz and van Wyk 1997), it is possible that the intake of nicotine via tobacco smoking 
or via nicotine replacement therapy during gestation and lactation, will reduce the blood 
and tissue vitamin C content of the neonate, thereby rendering it more susceptible to 
oxidant damage. It may also reduce the vitamin C content of the mother’s blood and thus 
the potential of the mother to protect the offspring against the harmful effects of nicotine. 
Maternal vitamin C supplementation during gestation and lactation may overcome the 
effect of nicotine on the blood vitamin C content of the mother's blood. This will ensure 
that enough vitamin C is available for development of the foetus and neonate and for its 
protection against the harmful effects of nicotine. Vitamin C also protects the DNA of the 
cells from the damage caused by free reactive oxygen species (ROS). It prevents harmful 
genetic alterations within cells (Gaby and Singh, 1991). Studies by Maritz (1993) also 
illustrated that maternal vitamin C supplementation during pregnancy and lactation 
prevented the inhibition of glycolysis in neonatal lung induced by maternal nicotine 
exposure. This means that vitamin C supplementation maintained a level in the blood of 
the mother and that of the foetus sufficient to protect the developing lung. 
 
Currently, as expected, maternal vitamin C supplementation and exposure to a 
combination of vitamin C and nicotine had no influence on the lung volumes of the 
offspring. The data from the present study also illustrated that the foetal lung was, 
contrary to expectations, adversely affected by maternal vitamin C supplementation, 
because vitamin C supplementation resulted in an increase in mean alveolar volumes in 
the offspring of the experimental animals. The mean alveolar volume of the animals that 
was born to the mothers who received vitamin C supplements during gestation and 
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lactation was the same as those that were expose to nicotine only. This might be due to a 
pro-oxidant effect of vitamin C (Paolini et al, 1999). If it is so, it means that the amount 
of vitamin C used to supplement the daily intake of the mother was too high. On the other 
hand, although the mean alveolar volume of the animals exposed to both nicotine and 
vitamin C tend to be lower than that of the control animals, it proved not significant (P 
>0.05), but it was significantly lower (P <0.05) than that of the nicotine-exposed animals.  
No apparent reason for this is can be attested to. However, since nicotine reduce the 
vitamin C content of lung tissue, it is possible that the level of vitamin C was too low for 
it to act as pro-oxidant (Harris, 1996). This conceivably resulted in a vitamin C level in 
the tissue that was within the levels that will enable it to act as an anti-oxidant and so 
prevented the oxidant activity of nicotine and other oxidants. It is thus conceivable that 
the adverse effects of nicotine and of excessive vitamin C was neutralized resulting in 
normal alveolar volume. Consequently the surface area available for gas exchange of the 
animals exposed to a combination of nicotine and vitamin C was larger than that of the 
animals that were exposed to nicotine only.  
 
Tobacco smoking activates neutrophils to generate reactive oxygen species (ROS) in the 
lung (Tate and Repine, 1984). These reactive species can then interact with the alpha-1-
proteinase inhibitor and inactivate this protective enzyme (Pryor, 1986). Vitamin C has 
been shown to protect human alpha-1-proteinase inhibitor from direct deactivation by 
nicotine as well as deactivation by free radicals generated by activated neutrophils (Pryor, 
1986). However, no white blood cells (WBC) are seen in lungs of vitamin C exposed rats 
or the rats that were exposed to nicotine during gestation and lactation. Therefore, the 
 
 
 
 
 87 
 
adverse effects of nicotine or vitamin C on the developing lung were not due to influx of 
white blood cells into the lungs and the consequent release of oxidants into the lungs, but 
rather to the effect of nicotine and vitamin C at tissue level. The results from this study 
show that vitamin C supplementation can potentially protect the lungs of the offspring 
against the adverse effects of maternal nicotine exposure. However, since it can act as 
pro-oxidant it is necessary to prevent the intake of too high doses of the vitamin, 
especially when pregnant. 
 
In conclusion, the partial protection by vitamin C can be attributed to the fact that vitamin 
C is water soluble while nicotine is water as well as lipid soluble (Yildiz, 2004). This 
may reduce the capacity of vitamin C to protect the lung against the oxidant effects of 
nicotine. It might be better to use a combination of vitamin C and fat soluble vitamins 
with anti-oxidant properties such as vitamin E or vitamin A or a combination thereof. 
This suggestion is supported by a study which showed that a combination of vitamins E 
and C maintain Bcl-2 in functional form by their membrane stabilizing action 
(Ramanathan et al, 2005). It also reduced oxidant induced apoptosis (Barrosso et al, 
1997). Further studies to establish whether a combination of these vitamins will protect 
the lungs of the offspring from the adverse effects of maternal nicotine exposure is 
necessary. 
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5.3. Maternal nicotine exposure and premature aging of the lungs – Future 
research 
An increase in alveolar volume and a decrease in the number of alveoli is a characteristic 
of senile emphysema. This is a condition that characterizes lung aging. In the present 
study it was shown that the lungs of the rats that were exposed to nicotine via the 
placenta and mother’s milk displayed signs that resemble those associated with premature 
aging and thus of senile emphysema. This means that maternal nicotine exposure during 
pregnancy and lactation, and thus during phases of rapid lung cell proliferation associated 
with lung growth and development, induced changes in the processes that control lung 
aging and maintenance of lung structure. As a consequence the lungs age prematurely. It 
is therefore likely that senescent cells will occur prematurely in the lungs of the nicotine 
exposed rats.  
 
In addition, suppression of glycolysis induces premature aging of cells (Kondoh et al, 
2007). Since maternal nicotine induce irreversible inhibition of glycolysis in the lungs of 
the offspring, it is conceivable that it will result in premature aging of the cells in the 
lung. Furthermore, experiments with human diploid fibroblasts (HDF) showed a drastic 
deregulation of carbohydrate metabolism in senescent cells. This is characterized by an 
imbalance of glycolytic enzyme activities and the failure to maintain ATP levels. This 
resulted in up-regulation of adenylate kinase and of the levels of AMP, which is known to 
act as a growth-suppressive signal that induces premature senescence (Zwerschke et al, 
2003). This further supports the findings of the present study because maternal nicotine 
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exposure increases the AMP content of the lungs of the offspring (Maritz and Burger, 
1993). 
 
Senescent cells not only loose their ability to divide and to respond to mitogenic stimuli, 
but also display alterations in morphology and metabolic profile (Bird et al, 2003). This 
phenotype can be induced by oxidative stress (Balin et al, 2002).  It is therefore plausible 
that factors that induce premature aging of lung fibroblasts will also affect not only 
growth and development of the lung, but will also adversely affect the maintenance of the 
lung structure and function since the fibroblasts provide part of the structural support and 
matrix that is important for its integrity (Absher, 1995). 
 
Zwerschke et al (2003) reported that about 90% of the consumed glucose in human 
diploid fibroblasts is converted to lactate. These cells displayed aerobic glycolysis, 
characterized by a high rate of lactate production from glucose in the presence of oxygen. 
It is interesting to note that more than 40% of the glucose consumed by lung tissue is also 
changed to lactate in the presence of adequate amounts of oxygen (Peterson et al, 1984, 
Kerr et al, 1979). The lactate is produced by the type I alveolar epithelial cells and in all 
likelihood the interstitial fibroblasts. Other cells such as the type II alveolar epithelial 
cells and alveolar macrophages have a very active Krebs cycle and respiratory chain 
which implies that most of the glucose consumed by these cells will be converted to CO2 
and H2O and ATP (Kerr et al, 1979). 
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The fact that the lifespan of many species can be extended through caloric restriction, 
suggests a critical role for alterations of carbohydrate metabolism in the control of 
regulatory processes that influence cell proliferation and survival (Lane et al, 2001). 
Studies by Lin and Neubauer (2000) established a new concept according to which 
changes in carbohydrate metabolism, and in particular the regulation of glycolytic energy 
production, contribute to the control and regulation of cell proliferation and survival. This 
indicates that glucose flux through glycolysis is important for normal growth, tissue 
maintenance and aging. 
 
Studies by Lee et al (2001) showed that the AMP levels increased drastically in senescent 
human diploid fibroblasts. Lee et al (2001) suggested that the increase is in all likelihood 
due to the up-regulation of adenylate kinase in these cells. Lee et al (2001) also 
demonstrated that the expression of genes involved in energy generating pathways in 
duodenum of aging rats, specifically cytochrome-c oxidase, ATP synthase and sodium-
potasium ATP-ase was down-regulated. Studies by Ethier et al (1989) also indicated an 
increase in adenosine release from cultured human lung fibroblasts from aged donors, 
which is likely due to an enhanced breakdown of ATP together with a concomitant 
increase in the AMP levels in these fibroblasts. The higher levels of AMP serve as a 
strong anti-proliferative signal on the cells and aging of the fibroblasts. It is therefore 
conceivable that changes in metabolic control which will result in a down-regulation of 
glycolysis and of and increase in AMP will result in premature aging of the lung 
fibroblasts and other lung cells. It was indeed shown by Muller et al (2006) that lung 
fibroblasts from patients with emphysema show markers of aging. It is therefore possible 
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that premature aging will induce development of emphysema earlier in animals that were 
exposed to nicotine via the placenta and mother’s milk as observed in this project. 
 
Since vitamin C prevents inhibition of glycolysis (Maritz, 1993), it is likely that vitamin 
C supplementation will prevent premature aging caused by a slow flux of glucose 
through this pathway. Since vitamin C is not completely prevented the harmful effects of 
maternal nicotine supplementation suggest that other mechanisms are also involved in 
inducing structural changes in the lungs of the offspring. Although no direct data is 
available to substantiate it, it is plausible that it was due to direct effect of nicotine on the 
DNA if the lung cells.  
 
Further studies are therefore important to establish 1) whether maternal nicotine exposure 
during pregnancy and lactation indeed induce premature aging in the lungs of the 
offspring, and 2) if so, whether it is due to an increased oxidant load in the lungs of the 
offspring of those exposed to nicotine via the placenta and mother’s milk. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 92 
 
CHAPTER 6 
 
Conclusion 
 
 
Several studies showed that maternal smoking interfere with lung growth and 
development in the offspring resulting in an increased incidence in respiratory diseases in 
the offspring (Huber, 1989). Nicotine is implicated as a causative factor and studies 
indeed illustrated that maternal nicotine exposure irreversible suppress glycolysis and 
glycogenolysis (Maritz, 1987). It was also shown that maternal nicotine exposure 
adversely affects structural development of the lungs of the offspring and thus rendering 
them more susceptible to disease (Dolley, 1995). 
 
The objectives of this study were therefore to: 
1. Determine the effect of maternal nicotine exposure during gestation and lactation 
on lung development from the end of the phase of rapid alveolar formation up to 
weaning on postnatal day 21, and 
2. The larger term effect on lung structure after weaning up to postnatal day 42. 
3. And whether vitamin C supplementation protects the lung against the effect of 
maternal nicotine exposure. Thus, lung integrity will be studied on rats during 
lactation and after lactation. It is important to note that the animals received 
nicotine and vitamin C only via the placenta and mother’s blood. After weaning 
the animals received no nicotine or vitamin C supplementation. 
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The most important findings are: 
1. Maternal nicotine exposure during gestation and lactation change the “program” 
that control normal aging. This is characterized by a decrease in alveolar number 
and increase in alveolar volume with a resultant decrease in internal surface area 
as the lung age. 
2. Maternal vitamin C supplementation during gestation and lactation also resulted 
in an increase in alveolar volume and a decrease in alveolar number. It is 
proposed that the changes seen are due to the pro-oxidant effect of excess vitamin 
C intake. 
3. Simultaneous exposure of the mother to both nicotine and vitamin C prevented 
most of the adverse effects on lung growth and development in the offspring. 
4. The data suggested that the adverse effect of maternal nicotine exposure is due to 
its oxidant properties. 
 
Based on the above data it is suggested that: 
    A. 1. Nicotine replacement therapy not to be used during pregnancy and lactation to 
quit smoking. 
    2. Vitamin C supplementation be used with caution.  
 
B. 1. Research be planned to establish whether maternal nicotine intake induce    
         premature lung aging, and 
            2. Whether premature aging is due to oxidant overload in the lungs of the    
                 offspring. 
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